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Nosocomial and community infections and biofilm formation from bacteria has 
increased significantly through adaptation combined with overuse of broad spectrum 
antibiotics. Because the world population continues to escalate, hospitals and long-term 
managed care will also escalate, thereby increasing transmission of infections, lowering 
patients’ quality of health. Another disease on the rise throughout the world is skin 
cancer.  A treatment modality that would cause less deleterious effects on the patient 
would be ideal. These two seemingly different issues could be solved with one product. 
First an inexpensive, safe, and non-selective antimicrobial surface coating would enhance 
the hospital arena and a coating that would treat skin cancer like wearing a band-aid 
would be patient friendly. We proposed two novel sub-coatings containing polymorphic 
Titanium dioxide, Br200 and BrNMP. Titanium dioxide is versatile, non-selective, and 
degrades compounds through photocatalytic oxidation. 
 The antibacterial sub-coating made of Poly(diallyldimethylammonium chloride) 
solution (PDDA) and Poly(4-styrenesulfonic acid) solution (PSS) in a 1:1 ratio of 0.1M 
PDDA/PSS as a 25 layer-by-layer coating on glass cover slips is known as the P sub-
coating. It contains Nitrogen and Sulfur molecules that were associated via low 
temperature liquid deposition with Br200 or BrNMP Titania. XRD and XPS evaluations 
of these P sub-coatings containing the polymorphic Br200 and BrNMP confirmed a 
match with the original properties of the loose nanoparticles. P sub-coating with these 
Titania under long range ultraviolet light and visible light were evaluated for Methyl 
Orange oxidative-degradation to quantify photocatalytic activity. UVA irradiation of 
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Br200 and BrNMP on the P sub-coating degraded Methyl Orange approximately two 
times faster than the same Titania on the control B sub-coating. The B sub-coating 
consisted of five mol of 3-glycidoxypropyl-trimethoxysilane mixed with 3 mol of 
Tetramethyl orthosilicate, prehydrolyzed with Ethanol and brought to pH 3 with Nitric 
acid.  
Light intensity, wavelength, surface material characteristics, and bacterial load 
affect efficiency of photo-oxidation. The super-hydrophilic nature of the polyelectrolyte-
Titania coating may attract and enhance photo-oxidative activity due to bacterial 
adherence via hydrophilic fimbriae that attach to biotic and abiotic surfaces. Br200 
demonstrated a stable working pH range including pH 3 to 4. The broad absorption edge 
of the polymorphic Brookite Titania Br200 and BrNMP enhanced by the N and S 
molecule surface interactions, and a narrowing of the band-gap, of the P sub-coating 
exhibited superior photocatalytic oxidative degradation on bacteria compared to the 
commercial P25 and vlp7000 Titania, or binder sub-coating with Titania. The 
polymorphic nature of Br200 and BrNMP may delay the electron/hole recombination 
centers due to electron transfer to different phases of crystallites. 
The LB sub-coating provided the polymorphic Titania with superior 
photocatalytic activity as compared to the P25 commercial product in vitro on HT-29 
human colon cancer cells and HTB-67 Human Melanoma cells. The novel P sub-coating 
with polymorphic Brookite Titania can provide a low cost, effective method for 
decreased transmission of bacterial infections and biofilm formation in the healthcare 
arena and community setting. The novel format of using FDA approved liquid band-aid 
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coated with Br200 non-selective Titania coating can provide lower pain and scarring in a 
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1.1 Uses and Characteristics of Titania as a Photocatalyst 
Titanium dioxide is a versatile compound that is used in many applications, 
industries, materials, and products throughout the world. It is used in pigments due to its 
extremely high refractive index of n = 2.7 [1]. The Huntsman Pigments Company, 
(Billingham, England) produces Rutile phase pigments for architectural paints for use in 
highly opaque surface coatings, powder coatings, plastics, inks, and paper applications. 
Anatase phase pigment is used for delustring synthetic fibers such as polyester and 
optical brighteners in ceramics. Photovoltaic solid-state hetero-junctions comprising a 
dense TiO2 film electrode as an electron conductor is another product [2]. In a medical 
application, a high compressive strength (>2 MPa) titanium oxide scaffold may be used 
in bone [3]. Hair dye, sun screens, and cosmetics are popular Titania containing products 
[4]. Chemical vapor deposition using Anatase phase for self-cleaning, super hydrophilic, 
antimicrobial glass [5].  Photomineralization with air and water purification, 
photoelectrodes as a hydrolysis catalyst, and photosterilization in sterilizing, deodorizing, 
and anti-fouling methods and products are all applications of Titania [6-7].  
 Characteristics of Titania or Titanium (IV) dioxide exhibit three polymorphic 
lattice phases, Rutile, Anatase, and Brookite. The most thermodynamically stable phase 
is Rutile because it has minimal electrostatic repulsive energy. Rutile is formed in a linear 
structure that is tetragonal and two of the twelve edges are shared in the octahedron [8]. 
Anatase phase is also tetragonal and shares four edges per octahedron without corner 
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oxygen sharing.  Brookite is unique with three shared edges per octahedron in an 
orthorhombic composure. Zallen and Moret measured the optical absorption edge of 
Brookite Titania and saw that its phase extends throughout the visible light range [9]. 
Brookite was observed to have a broad absorption edge in contrast to the steep absorption 
edges of Anatase and Rutile. No evidence of a direct gap was observed in the evaluated 
spectral range. It was proposed that Brookite phase Titania is an indirect-gap 
semiconductor with an approximate bandgap of 1.9 eV [9]. In contrast, calculations using 
the self-consistent orthogonalized linear-combination-of-atomic-orbitals method, Mo and 
Ching, 1995 approximated a direct bandgap for Brookite [10]. Other researchers have 
determined that all three phases of Titania have similar direct bandgap energies (~3.1 + 
0.1 eV) [11]. Banerjee and colleagues report different bandgap values for each phase, 
Anatase (3.2 eV), Rutile (3.02 eV), and Brookite (2.96 eV) [12]. Whether direct or 
indirect, Brookite phase Titania exhibits the lowest bandgap energy.  
Characteristics of a photocatalyst were described as its ability to simultaneously 
adsorb two reactants [12]. Then efficiently absorb light (hv > Eg) to reduce and oxidize 
the adsorbed reactants. In order to excite the electron (e-) from the valence band to the 
conduction band producing an e--h+ pair, the absorbed light energy must be equal or 
larger than the bandgap without being consumed. The produced hydroxyl radicals oxidize 
holes in the cells walls / membranes allowing the contents to leak out and also be 
degraded. Superoxide anions (.O2-) can enter the cells through the holes in the cell walls 
and produce Reactive oxygen species (ROS), such as H2O2 molecules that will 
decompose DNA via the Fenton Reaction. 
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Ions such as Phosphate have a very high affinity for Titania and can significantly 
decrease the photocatalytic activity. The substrate, ions, diluent, surface roughness, 
hydrophilicity or hydrophobicity, morphology, particle size, surface area, and crystal 
structure, absorption edge type, direct or indirect bandgap, bandgap size, number of 
exposed active sites, are all factors that influence the amount of photocatalytic activity on 
Titania [12].  
 
1.2 Significance of Bacteria, Biofilm, and Overuse of Antibiotics 
Significant overuse of broad spectrum antibiotics has escalated the emergence of 
bacterial resistance. These Multi-Drug Resistant (MDR) bacterial infections increase the 
morbidity and mortality of patients. Therefore, nosocomial infections of bacteria such as 
Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli are expected to rise. 
The CDC states that approximately 65% of infections are found in biofilms. 
 Currently, antibiotics provide a selective method of bacterial elimination, but are 
losing the battle against emerging resistant pathogens. A rising problem consists of 
bacteria sharing plasmids, crossing specie boundaries. In Brooklyn, New York three 
hospitals isolated E. coli from UTIs that possessed 23-kb plasmid encoding Klebsiella 
pneumonia carbapenemase type 2 (KPC-2) and increasingly containing the gene blaKPC-2 
[13].  The gram-negative multi-drug-resistant (MDR) bacteria Acinetobacter baumannii 
is ubiquitous and can be isolated from water, soil, animals, humans, and other 
environmental sources [14]. It is aerobic and an opportunistic pathogen escalating 
nosocomial outbreaks in intensive-care-units (ICU) and burn units [15] [16] [17]. The 
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mechanisms which allow for such MDR in A. baumannii could be that they amass 
quickly and exchange genetic information easily [16, 18]. Recently a clinical isolate of 
that produced extended-spectrum β-lactamase but was carbapenem-susceptible, contained 
more than 40 identified resistance genes [19]. This unique class of Gram-negative 
bacteria may easily share genetic pools where prevalent clonal groups of A. baumannii 
co-exist via horizontal gene transfer [16, 18, 20].  Clonal expansion may work 
additionally to increase resistance [20]. 
Another method of resistance is chromosomal cassette transfer [21]. DNA damaging 
antibiotics depress SOS-regulated polymerases via LexA cleavage inducing resistant 
mutations [22]. SOS-independent response increased frameshift mutations when exposed 
to β-lactam antibiotics [23]. A. baumannii contains an over-expressed efflux pump 
affecting many type of antibiotics [24]. Sub-lethal levels of antibiotics induce 
mutagenesis via reactive oxygen species (ROS). The bacteria remained sensitive to the 
utilized antibiotic, but increased mutant strains that were resistant to other antibiotics 
[25].  
Another mechanism that bacteria use to protect themselves is by creating and 
living in biofilms [26].  Bacteria change from planktonic to sessile existence through 
attachment to surfaces. Generating a gooey matrix and signaling (quorum sensing (QS)) 
one another to proliferate into a microcolony, offers a selective advantage to increase 
their survival rate. [27]. Other species of bacteria may join the colony due to QS signals 
released into the environment. These chemical gradients allow for a diverse species to 
coexist. Lastly, some cells escape from the colony and return to the planktonic state 
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moving and landing in a different location to start the process of biofilm formation again. 
Biofilms are ubiquitous and the CDC estimates that biofilms are involved in at least 65% 
of all infections [28]. 
Reisner and colleagues determined that biofilm formation was significantly 
dependent on growth medium composition [29]. Specific adhesion to D-mannose 
demonstrated direct binding of FimH type 1 pili which is serologically conserved 
throughout Enterobacteriaceae [30]. EC and many other species of bacteria contain 
hydrophilic fimbriae that attach to biotic and abiotic surfaces [31-32].   
E. coli B was chosen as the model bacteria in this work was for the following 
reasons. First, E. coli B contains the fimH gene, which codes for the hydrophilic FimH 
subunit of type 1 pili conferring attachment to biotic and abiotic surfaces. QS in E. coli is 
capable of binding to and responding to exogenous Acetylhomoserine lactone (AHL), 
and regulate target gene expression  and adjust cellular functions to match the 
environment [33].  
When microorganisms attach to a surface and grow as biofilm, they become less 
susceptible to antimicrobials than the same microbes in planktonic growth. Several 
factors are responsible for biofilm resistance including restricted penetration of 
antimicrobials into a biofilm, decreased growth rate, and expression of resistance genes 
[34-36]. 
Exopolymer matrix of biofilms can restrict diffusion of drugs. Diffusion rate in a 
biofilm is approximately 20 to 80 percent of that in free floating planktonic state [37]. 
The negatively charged exopolysaccharide is also effective against positively charged 
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antibiotics retarding permeation [38-39]. Another biofilm-reduced susceptibility could be 
contributed to the slower growing rate or non-growing status, or increased stress 
responses of microbial cells in biofilm due to limited diffusion of oxygen, nutrients, or 
starvation protecting the biofilm from environmental stresses [40] [41].  
Different strategies [26] to prevent or eradicate bacteria biofilms include: 
prevention of attachment or QS [42-45]. A super-hydrophilic surface with a contact angle 
of <5o is used and may attract the hydrophilic heads of bacterial fimbriae to the surface 
[46]. Hydroxyl radicals would successively attack the bacterial cell walls and membranes 
through the photocatalytic activity of the UVA or visible light (VL) irradiated surface. 
Titanium dioxide water structure at the TiO2/aqueous interface is significantly dependent 
on the specific nature of the ions present in the diluent and the pH for optimized 
photocatalytic activity. 
 
1.3 Significance of Skin Cancer and Current Treatments 
In the United States Skin cancer is the most common form of cancer with basal 
cell and squamous cell carcinomas being the two highest common types. Malignant 
Melanoma is highly dangerous among younger people. Exposure to ultraviolet (UV) light 
or sunlight, or tanning beds, or other sources of man-made UV such as fingernail polish 
curing with UV causes approximately 65%–90% of melanomas [47]. In the U.S. in 2006, 
53,919 people were diagnosed with skin melanomas and 8,441 people in the United 
States died from skin melanomas [48]. Protection from UV light will prevent most skin 
cancers [47].  People living in areas of the earth that receive high levels of UV radiation 
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are at higher risk developing skin cancer [49]. Skin cancer is an accumulative 
phenomenon and is related to lifetime exposure to UV radiation. The time of day such as 
midday presents a higher chance of cancer. Normal skin or in an existing mole can 
becomes cancerous; Melanoma can develop anywhere on your body. Indicators of 
Melanoma include moles with irregular borders and different colors, lesions on palms of 
hands or feet, large multicolored spots with darker speckles, a mole that changes color, 
size, or bleeds. 
Exposure to photocatalytically activated Anatase phase Titanium  dioxide resulted 
in a dose-dependent decrease of cell-viability in goldfish cells [50]. With similar results, 
another research group used TiO2 nanoparticles (DeGussa) that were 75% Rutile and 
25% Anatase crystalline phase in free suspension [51].  
In human hepatoma Bel-7402 cells, apoptosis induced by the photocatalytically 
activated TiO2 nanoparticles was determined to be the primary mechanism of cell death 
[52].  The small size with large surface area and unique characteristics of TiO2 
nanoparticles may facilitate absorption and transport across the barriers of mammalian 
epithelium (skin, lungs, and gut) followed with systemic entry to the circulatory system 
to secondary target organs and may even cross the blood-brain barrier to reside in the 
brain [53-54].  
Opposing the above theory, Kiss and colleagues (2008) investigated the 
possibility of TiO2 particles penetrating through the stratum corneum in human skin 
xenografts onto nude mice [55].  The stratum corneum funtioned to keep the TiO2 
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nannoparticles from traveling further through intact skin.  Photocatalytically activated 
Titania may prove to be a treatment modality for skin cancer. 
 
1.4 Relevant Previous Research by Our Collaborators  
 The minimization of lattice defects and influennce of hydroxyl content were 
evaaluated. Water-based Ambient Condition Sol (WACS) post-treated by a Solvent-
based Ambient Condition Sol (SACS) process in sec-butanol (sec-BuOH), processed 
primarily Brookite phase Titania. A polar solvent, N-methylpyrrolidone (NMP), was used 
to alter polymorphic Titania nanoparticles to increase photocatalytic activity by 
extracting lattice hydroxyls and adorn nitrogen on the surface of the Titania 
nanoparticles. The nanoparticles were well characterized and the photocatalytic activity 
was evaluated via Methyl orange oxidative degradation by exposure to either a 182 Watt 
UVA lamp or a 150 Watt Halogen lamp. Two types of polymorphic Titania were 
produced, Br200 and BrNMP. 
 
1.5 Relevant Previous Research by Our Lab 
 A free suspension assay was developed and evaluated Titania nanoparticles under 
UVA (365 nm) exposure on bacteria. A working concentration of Titania in free 
suspension was established. While the method is accurate and highly reproducible, it used 
a lot of material, time, money, and labor. A preliminary coating study with Titania 




Previous research was deficient in the following items. A complete death curve 
was never identified. Only UVA (365 nm) provided useable data. Titania was mixed with 
Binder provided by our collaborators. The method used, coated all sides of the crystal 
lattice, and cells numbers were not significantly reduced in 30 minutes of UVA exposure. 
A fast miniaturized assay was not created. Visible light exposure of Br200 and P25 in a 
free suspension assay only gained a 3 log reduction difference after 8 hours of exposure. 
BrNMP was not evaluated.  From the above it is evident that the Specific Aims and 
Objectives of my research are different and advance the knowledge of this line of 
research. 
 
1.6 Significance of This Research to the Scientific Community 
The significance of the proposed research is to aid in the prevention of 
transmission of bacteria in the nosocomial and community settings. Developing a suitable 
coating for hospitals and long-term managed care facilities would enhance the patients’ 
lives by preventing bacterial infections that can easily cause death, and increase the 
length of the patients’ lives. The surface coating must be safe, effective, inexpensive, 
durable, and easy to install and care for. Therefore, two different types of polymorphic 
Brookite will be evaluated under UVA and VIS light separately, comparing them to the 
appropriate controls and commercial samples. Developing a sub-coating with the above 
characteristics, that will enhance the photocatalytic activity of the Titania, for work under 
VIS light irradiation in a timely manner. The success of this new research would 
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significantly enhance the well-being of people’s lives in the nosocomial and community 
settings. 
Even more differently, examination of these Titania with coatings for cancer 
treatments will be evaluated. Proving these novel methods and coatings work well would 
help cancer patients have less scarring and deleterious effects from cancer treatment. This 
new research would significantly enhance cancer patients’ lives. Therefore, this research 
is different from prior work and has the possibility of significantly impacting the body of 
Science and increasing the quality of life significantly for many people. 
Current Status 
We have the two types of polymorphic Brookite Titania graciously provided to us by 
our collaborators, Dr. Lee and Dr. Kaewgun. Through prior evaluations with the free 
suspension bioassay, we have a partial death curve and a working concentration with in 
which to start our new and further developing research. 
 
1.7 Research Objectives 
Therefore my objectives for my research include the following: 
• Modify and miniaturize the free suspension assay 
• Adapt the modified and miniaturized assay for use with coatings 
• Develop a sub-coating for the Titania, and characterize it to confirm a match with 
the original properties of the loose nanoparticles.  
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• Determine the death curve of each appropriate type of Titania under UVA in free 
suspension 
• Determine the death curve of each appropriate type of Titania under VL in free 
suspension 
• Evaluate the photocatalytic ability of free suspension Titania under UVA light on 
Methyl Orange oxidative-degradation to verify activity in the new assay format 
• Evaluate the photocatalytic ability of free suspension Titania under VL light on 
Methyl Orange oxidative-degradation to verify activity in the new assay format 
• Determine the death curve of each appropriate type of Titania under UVA on 
novel sub-coating with Titania 
• Determine the death curve of each appropriate type of Titania under VL on novel 
sub-coating with Titania 
• Evaluate the photocatalytic ability of sub-coating with appropriate Titania under 
UVA light on Methyl Orange oxidative-degradation to verify activity 
• Evaluate the photocatalytic ability of sub-coating with appropriate Titania under 
VL light on Methyl Orange oxidative-degradation to verify activity in the new 
assay format  
• Based upon those results, choose the best candidate for evaluation of the most 
active form of free suspension Titania on cancer cells in vitro as a feasibility proof 
of concept model  
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• Based upon those results, choose the best candidate for evaluation of a second 
novel sub-coating containing the most active form of Titania on cancer cells in 
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2.1 Titania, Characteristics, Current Products, and Uses 
Titania or Titanium dioxide (TiO2) degrades compounds through photo-oxidation 
making it a versatile non-selective compound with photocatalytic properties. Titanium 
dioxide exists in three different polymorphic lattice phases, Anatase, Brookite, and 
Rutile. Rutile phase has minimal electrostatic repulsive energy, and is the most 
thermodynamically stable due to its abridged in a linear structure with two of the twelve 
edges shared in the octahedron [8]. Anatase phase shares four edges per octahedron 
without corner oxygen sharing.  Uniquely, Brookite phase is composed orthorhombically 
with three shared edges per octahedron. Zallen and Moret measured the optical 
absorption edge of Brookite Titania [9]. The optical absorption edge of Brookite phase 
extends throughout the visible light range. Brookite was observed to have a broad 
absorption edge in contrast to the steep absorption edges of Anatase and Rutile. No 
evidence of a direct gap was observed in the evaluated spectral range. It was proposed 
that Brookite phase Titania is an indirect-gap semiconductor with an approximate 
bandgap of 1.9 eV [9]. In contrast, calculations using the self-consistent orthogonalized 
linear-combination-of-atomic-orbitals method, Mo and Ching, 1995 approximated a 
direct bandgap for Brookite [10]. Other researchers have determined that all three phases 
of Titania have similar direct bandgap energies (~3.1 + 0.1 eV) [11]. Banerjee and 
colleagues report different bandgap values for each phase, Anatase (3.2 eV), Rutile (3.02 
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eV), and Brookite (2.96 eV) [12]. Whether direct or indirect, Brookite phase Titania 
exhibits the lowest bandgap energy. 
Characteristics of a photocatalyst were described as its ability to simultaneously 
adsorb two reactants [12]. Then efficiently absorb light (hv > Eg) to reduce and oxidize 
the adsorbed reactants. In order to excite the e- from the valence band to the conduction 
band producing an e--h+ pair, the absorbed light energy must be equal or larger than the 
bandgap without being consumed. The produced hydroxyl radicals oxidize holes in the 
cells walls / membranes allowing the contents to leak out and also be degraded. 
Superoxide anions (.O2-) eventually produce Reactive oxygen species (ROS), H2O2 
molecules decomposing DNA via the Fenton Reaction. 
Ions such as Phosphate have a very high affinity for the Titania and can 
significantly decrease the photocatalytic activity. The substrate, ions, diluent, surface 
roughness, hydrophilicity or hydrophobicity, morphology, particle size, surface area, and 
crystal structure are factors that influence the amount of photocatalytic activity [12]. 
Titanium dioxide is a versatile compound that is used in many applications, 
industries, materials, and products throughout the world. It is used in pigments due to it 
extremely high refractive index of n = 2.7 [1]. The Huntsman Pigments Company, 
(Billingham, England) produces Rutile phase pigments for architectural paints for use in 
highly opaque surface coatings, powder coatings, plastics, inks, and paper applications. 
Huntsman produces Anatase phase pigment for delustring synthetic fibers such as 
polyester and optical brighteners in ceramics. Another company makes photovoltaic 
solid-state hetero-junctions comprising a dense TiO2 film electrode as an electron 
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conductor [2]. In a medical application, a high compressive strength (>2 MPa) titanium 
oxide scaffold may be used in bone [3]. Hair dye, sun screens, and cosmetics are popular 
Titania containing products [4]. Chemical vapor deposition using Anatase phase for self-
cleaning, super hydrophilic, antimicrobial glass [5].  Photomineralization with air and 
water purification, photoelectrodes as a hydrolysis catalyst, and photosterilization in 
sterilizing, deodorizing, and anti-fouling methods and products [6-7].  
 
2.2 Bacteria, Biofilm, and Overuse of Antibiotics 
Significant overuse of broad spectrum antibiotics has escalated the emergence of 
bacterial resistance. These Multi-Drug Resistant (MDR) bacterial infections increase the 
morbidity and mortality of patients. Therefore, nosocomial infections of bacteria such as 
Staphylococcus aureus, Acinetobacter baumannii, Escherichia coli are expected to rise.   
 Currently, antibiotics provide a selective method of bacterial elimination, but are 
losing the battle against emerging resistant pathogens. A rising problem consists of 
bacteria sharing plasmids, crossing specie boundaries. In Brooklyn, New York three 
hospitals isolated E. coli from UTIs that possessed 23-kb plasmid encoding Klebsiella 
pneumonia carbapenemase type 2 (KPC-2) and increasingly containing the gene blaKPC-2 
[13].  The gram-negative multi-drug-resistant (MDR) bacteria Acinetobacter baumannii 
is ubiquitous and can be isolated from water, soil, animals, humans, and other 
environmental sources [14]. It is aerobic and an opportunistic pathogen escalating 
nosocomial outbreaks in intensive-care-units (ICU) and burn units [15] [16] [17]. The 
mechanisms which allow for such MDR in A. baumannii could be that they amass 
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quickly and exchange genetic information easily [16, 18]. Recently a clinical isolate of 
that produced extended-spectrum β-lactamase but was carbapenem-susceptible, contained 
more than 40 identified resistance genes [19]. This unique class of Gram-negative 
bacteria may easily share genetic pools where prevalent clonal groups of A. baumannii 
co-exist via horizontal gene transfer [16, 18, 20].  Clonal expansion may work 
additionally to increase resistance [20]. 
Another method of resistance is chromosomal cassette transfer [21]. DNA 
damaging antibiotics depress SOS-regulated polymerases via LexA cleavage inducing 
resistant mutations [22]. SOS-independent response increased frameshift mutations when 
exposed to β-lactam antibiotics [23]. A. baumannii contains an over-expressed efflux 
pump affecting many type of antibiotics [24]. Sub-lethal levels of antibiotics induce 
mutagenesis via reactive oxygen species (ROS). The bacteria remained sensitive to the 
utilized antibiotic, but increased mutant strains that were resistant to other antibiotics 
[25].  
Another mechanism that bacteria use to protect themselves is by creating and 
living in biofilms [26].  Bacteria change from planktonic to sessile existence through 
attachment to surfaces. Generating a gooey matrix and signaling (quorum sensing (QS)) 
one another to proliferate into a microcolony, offers a selective advantage to increase 
their survival rate. [27]. Other species of bacteria may join the colony due to QS signals 
released into the environment. These chemical gradients allow for a diverse species to 
coexist. Lastly, some cells escape from the colony and return to the planktonic state 
moving and landing in a different location to start the process of biofilm formation again. 
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Biofilms are ubiquitous and the CDC estimates that biofilms are involved in at least 65% 
of all infections [28]. 
Reisner and colleagues determined that biofilm formation was significantly 
dependent on growth medium composition [29]. Specific adhesion to D-mannose 
demonstrated direct binding of FimH type 1 pili which is serologically conserved 
throughout Enterobacteriaceae [30]. EC and many other species of bacteria contain 
hydrophilic fimbriae that attach to biotic and abiotic surfaces [31-32].   
E. coli B was chosen as the model bacteria in this work was for the following 
reasons. First, E. coli B contains the fimH gene, which codes for the hydrophilic FimH 
subunit of type 1 pili conferring attachment to biotic and abiotic surfaces. QS in E. coli is 
capable of binding to and responding to exogenous Acetylhomoserine lactone (AHL), 
and regulate target gene expression  and adjust cellular functions to match the 
environment [33].  
When microorganisms attach to a surface and grow as biofilm, they become less 
susceptible to antimicrobials than the same microbes in planktonic growth. Several 
factors are responsible for biofilm resistance including restricted penetration of 
antimicrobials into a biofilm, decreased growth rate, and expression of resistance genes 
[34-36]. 
Exopolymer matrix of biofilms can restrict diffusion of drugs. Diffusion rate in a 
biofilm is approximately 20 to 80 percent of that in free floating planktonic state [37]. 
The negatively charged exopolysaccharide is also effective against positively charged 
antibiotics retarding permeation [38-39]. Another biofilm-reduced susceptibility could be 
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contributed to the slower growing rate or non-growing status, or increased stress 
responses of microbial cells in biofilm due to limited diffusion of oxygen, nutrients, or 
starvation protecting the biofilm from environmental stresses [40] [41].  
Different strategies [26] to prevent or eradicate bacteria biofilms include: 
prevention of attachment or QS [42-45]. A super-hydrophilic surface with a contact angle 
of <5o is used and may attract the hydrophilic heads of bacterial fimbriae to the surface 
[46]. Hydroxyl radicals would successively attack the bacterial cell walls and membranes 
through the photocatalytic activity of the UVA or visible light (VL) irradiated surface. As 
Titanium dioxide water structure at the TiO2/aqueous interface is significantly dependent 
on the specific nature of the ions present in the diluent and the pH for optimized 
photocatalytic activity. 
 
2.3 Skin Cancer 
In the United States Skin cancer is the most common form of cancer with basal 
cell and squamous cell carcinomas being the two highest common types. Melanoma is 
highly dangerous among younger people. Exposure to ultraviolet (UV) light or sunlight, 
or tanning beds, or other sources of man-made UV such as fingernail polish curing with 
UV causes approximately 65%–90% of melanomas [47]. In the U.S. in 2006, 53,919 
people were diagnosed with skin melanomas and 8,441 people in the United States died 
from skin melanomas [48]. Protection from UV light will prevent most skin cancers [47].  
People living in areas of the earth that receive high levels of UV radiation are at higher 
risk developing skin cancer [49]. Skin cancer is an accumulative phenomenon and is 
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related to lifetime exposure to UV radiation. The time of day such as midday presents a 
higher chance of cancer. Normal skin or in an existing mole can becomes cancerous; 
Melanoma can develop anywhere on your body. Indicators of Melanoma include moles 
with irregular borders and different colors, lesions on palms of hands or feet, large 
multicolored spots with darker speckles, a mole that changes color, size, or bleeds. 
Skin Cancer Research 
Exposure to photocatalytically activated Anatase phase Titanium  dioxide resulted 
in a dose-dependent decrease of cell-viability in goldfish cells [50]. With similar results, 
another research group used TiO2 nanoparticles (DeGussa) that were 75% Rutile and 
25% Anatase crystalline phase in free suspension [51].  
In human hepatoma Bel-7402 cells, apoptosis induced by the photocatalytically 
activated TiO2 nanoparticles was determined to be the primary mechanism of cell death 
[52].  The small size with large surface area and unique characteristics of TiO2 
nanoparticles may facilitate absorption and transport across the barriers of mammalian 
epithelium (skin, lungs, and gut) followed with systemic entry to the circulatory system 
to secondary target organs and may even cross the blood-brain barrier to reside in the 
brain [53-54].  
Opposing the above theory, Kiss and colleagues (2008) investigated the 
possibility of TiO2 particles penetrating through the stratum corneum in human skin 
xenografts onto nude mice [55].  The stratum corneum funtioned to keep the TiO2 
nannoparticles from traveling further through the intact skin.  Titania may prove to be a 
treatment modality for skin cancer. 
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3.1 Abstract  
 
Nosocomial infections are rising due to bacterial adaptation combined with 
overuse of broad spectrum antibiotics which significantly increased emergence of 
resistant pathogens. Because about sixty-five percent of all bacterial infections are 
biofilm associated, an inexpensive, durable, safe, visible-light activated, and non-
selective antimicrobial surface coating is ideal. Titanium dioxide, a versatile non-
selective compound with photocatalytic properties, degrades compounds through photo-
oxidation. Titanium dioxide exists in three lattice phases, Anatase, Brookite, and Rutile, 
with Anatase used extensively. Without doping or close atomic association with another 
specific atom causing band-gap narrowing, Titanium dioxide is active under long wave 
ultraviolet light (365 nm) and not visible light. Studies incorporating doping of atoms into 
the crystal lattice structure can only be performed at temperatures higher than the phase 
transition temperature for Brookite, causing Anatase or Rutile lattice configurations.  In 
order to maintain the Brookite phase of the Titanium dioxide, this study evaluated a novel 
super hydrophilic polyelectrolyte sub-coating.  Room temperature deposition maintained 
the Brookite lattice phase and provided atomic surface associations between the sub-
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coating and the Titania. The sub-coating contained Nitrogen and Sulfur molecules. With 
their surface associations to the Titania, it was proposed to narrow the band-gap, causing 
visible-light photocatalytic activity. In conjunction with the sub-coating, two types of 
polymorphic Brookite phase Titania were evaluated, Br200 and BrNMP. 
PDDA/PSS sub-coatings were successfully attached to glass cover-slips in a 25 
layer-by-layer room temperature liquid deposition method. Each type of Titania 
evaluated was attached to the PDDA/PSS sub-coated cover-slips by room temperature 
liquid phase deposition via XPS analysis.  Appropriate molecules of O 1s, N 1s, S 2P and 
Ti 2p were found on the surface of the cover-slips. XRD analysis determined that 
predominantly Brookite phase with some Anatase phase and a small amount of Rutile 
phase Titania lattice structures remained on the surface of the cover-slips matching peaks 
with the powder Titania samples. The PDDA/PSS sub-coating was found to be 
photocatalytically active under visible light on Methyl orange degradation and had 
bactericidal activity on E. coli B. Visible-light photocatalytically activated super 
hydrophilic polyelectrolyte sub-coating with vlp7000, Br200, or BrNMP Titania killed all 
E. coli B in 40, 8, or 30 minutes, respectively, or with binder sub-coating plus each type 
of Titania eliminated all E. coli B in 60, 50, or 50 minutes, respectively.   
Light intensity, wavelength, amount of surface area, size of each crystallite, 
surface material characteristics, pH, band gap, efficiency of hole-electron recombination, 
amount of dissolved oxygen, broad absorption edge (indirect bandgap) versus sharp 
absorption edge (direct bandgap), number of available active surface sites, and bacterial 
load affect efficiency of photo-oxidation. The super-hydrophilic nature of the 
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polyelectrolyte-Titania coating attracts and enhances photo-oxidative activity due to 
bacterial adherence via hydrophilic fimbriae that attach to biotic and abiotic surfaces. 
Br200 demonstrated a stable working pH range including pH3 to 4. The 5-8nm diameter 
crystallite size range provides a large surface area, changing the characteristics from a 
monolithic nature to Nitrogen and Sulfur molecules being able to associate with the 
crystal lattice structures on the surface of each surface crystallite, and significantly 
increasing target contact probability. We suggest that the association of the Nitrogen and 
Sulfur molecules on the sub-coating interact with the surface of the lattice structures on 
each nanoparticle surface, enhancing visible light photo activity by narrowing the band-
gap and slowing the electron/hole recombination. Br200 and BrNMP Titania on the 
polyelectrolyte sub-coating provided superior photo-oxidative activity on both Methyl 
orange degradation and bacterial decomposition compared to the commercial P25 and 
vlp7000 Titania, or binder sub-coating with Titania. Further characterization and 
evaluation of these PDDA/PSS sub-coatings with Br200 or BrNMP are warranted. 
Furthermore, the Br200 may have been more photocatalytically active than the BrNMP in 
association with the sub-coatings on E. coli B. This phenomenon may be caused by the 
low manufacturing and calcination temperatures of BrNMP. Some charred NMP residue 
may have remained on the Titania surface and blocked some of the photoactive sites and 
aided in electron/hole recombination. Also the bacteria may not have been as attracted to 
the residue covered surface of BrNMP. These novel polyelectrolyte-Br200 or 
polyelectrolyte-BrNMP non-selective Titania coatings would provide a low cost,  visible-
light active, safe, and effective non-selective method to aid in preventing transmission of 
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bacterial infections and in prevention of biofilm formation in the nosocomial and 
community settings. 
3.2 Introduction  
 Worldwide exploitation of broad spectrum antibiotics significantly increased 
emergence of bacterial resistance. Bacterial infections increase the morbidity and 
mortality of patients in war zones, acute or long-term care hospitals. As the world 
population increases and people travel further and live longer, they will require more 
hospital and long-term managed care. Therefore, nosocomial infections of bacteria such 
as Escherichia coli are expected to rise.   
 Currently, antibiotics provide a selective method of bacterial elimination, but are 
losing the battle against emerging resistant pathogens. A rising problem consists of 
bacteria sharing plasmids, crossing specie boundaries. Hospitals isolated E. coli from 
UTIs that possessed 23-kb plasmid encoding Klebsiella pneumonia carbapenemase type 2 
(KPC-2) and increasingly containing the gene blaKPC-2 [13].  The gram-negative multi-
drug-resistant (MDR) bacteria Acinetobacter baumannii is ubiquitous and can be isolated 
from water, soil, animals, humans, and other environmental sources [14]. It is aerobic and 
an opportunistic pathogen escalating nosocomial outbreaks in intensive-care-units (ICU) 
and burn units [15] [16] [17]. The mechanisms which allow for such MDR in A. 
baumannii could be that they amass quickly and exchange genetic information easily [16, 
18]. A. baumannii extended-spectrum β-lactamase isolates containing more than 40 
identified resistance genes have been identified [19]. This unique class of Gram-negative 
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bacteria may easily share genetic pools where prevalent clonal groups of A. baumannii 
co-exist via horizontal gene transfer [16, 18, 20].  Clonal expansion may work 
additionally to increase resistance [20]. 
Another method of resistance is chromosomal cassette transfer. Staphylococcus 
aureus contains the staphylococcal chromosomal cassette (SCCmec), in which the gene 
mecA encodes for PBP2a causing low binding affinity to β-lactam antibiotics thus 
rendering them ineffective on cell wall synthesis disruption [21]. DNA damaging 
antibiotics such as ciprofloxacin depresses SOS-regulated polymerases via LexA 
cleavage inducing resistant mutations [22]. SOS-independent response by induction of 
DinB increased frameshift mutations when exposed to β-lactam antibiotics [23]. A. 
baumannii contains an over-expressed efflux pump affecting fluoroquinolones, 
tetracyclines, aminoglycosides, erythromycin, cefotaxime, and trimethoprim [24]. 
Kohanski and colleagues recently identified an increase in reactive oxygen species (ROS) 
due to exposure to sub-lethal levels of antibiotics induce mutagenesis. The bacteria 
remained sensitive to the utilized antibiotic, but increased mutant strains that were 
resistant to other antibiotics [25].  
Another mechanism that bacteria use to protect themselves is by creating and 
living in biofilms. Costerton and Stewart (2006) put together a theory of how biofilms 
develop [26].  Within natural, medical, and engineered environments, free-swimming 
(planktonic) bacteria land on a surface, aggregate and affix to living and abiotic surfaces, 
causing the bacteria to change from its planktonic state to a sessile existence. Generating 
a gooey matrix and signaling (quorum sensing) one another to proliferate into a 
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microcolony, offers a selective advantage to increase their survival rate. Although not 
adhered directly to the surface, some bacteria in the matrix may grow a polysaccharide 
capsule for protection, remaining dormant until favorable environmental conditions arise 
[27]. Other species of bacteria may join the colony due to chemical auto-induced signals 
released into the environment. These chemical gradients allow different metabolic states 
and diverse species to coexist. Lastly, some cells escape from the colony and return to the 
planktonic state moving and landing in a different location to start the process of biofilm 
formation again. Biofilms are ubiquitous and implicated in several infectious processes 
including nosocomial infections such as indwelling devices and chronic infections. The 
CDC estimates that biofilms are involved in at least 65% of all infections [28]. 
Reisner and colleagues determined that biofilm formation was significantly 
dependent on growth medium composition, rather than the association between 
pathogenic E. coli, increased biofilm formation, to commensal E. coli K-12 strains that 
normally reside within the mucus layer without colonizing the epithelium  [29]. Krogfelt 
and researchers (1990) used a carrier protein attached to D-mannose to demonstrate direct 
binding of FimH the mannose-specific adhesion. FimH was visualized by electron 
microscopy. The FimH adhesin of the type 1 pilus is serologically conserved throughout 
Enterobacteriaceae [30]. Electron Microscopy depicted a 16 nm fibrillar tip structure 
joined end to end on the pilus rod with structural design matching the FimG-FimH 
complex. .  EC and many other species of bacteria contain hydrophilic fimbriae that 
attach to biotic and abiotic surfaces [31-32].   
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E. coli B was chosen as the model bacteria in this work was for the following 
reasons. First, E. coli B contains the fimH gene, which codes for the hydrophilic FimH 
subunit of type 1 pili conferring attachment to biotic and abiotic surfaces. In the 
Vandemaele study, greater than ninety nine percent homology was indicated among 
strains from either bovine (B), avian (A), or porcine (P) species. Of the 24 strains tested, 
all contained the fimH gene except strain P3.  Secondly, Quorum Sensing was examined. 
E. coli contains the signal receptor protein SdiA of the luxR family. The SdiA receptor 
protein is capable of binding to and responding to exogenous AHLs, but not producing 
them, therefore regulating target gene expression [33]. SdiA also responds to endogenous 
indole, allowing the bacteria to adjust cellular functions correctly in the biofilm 
environment [56]. The signal generating enzyme was found to be a LuxS homologue 
producing AI-2.   
When microorganisms attach to a surface and grow as biofilm, they become less 
susceptible to antimicrobials than the same microbes in planktonic growth. Several 
factors are responsible for biofilm resistance including restricted penetration of 
antimicrobials into a biofilm, decreased growth rate, and expression of resistance genes 
[34-36]. 
Biofilms are enclosed in a self-produced exopolymer matrix that can restrict 
simple diffusion of drugs. Diffusion rate in a biofilm is approximately 20 to 80 percent of 
that in free floating planktonic state [37]. The negatively charged exopolysaccharide is 
also effective against positively charged antibiotics, e.g. aminoglycoside, retarding their 
permeation [38-39]. Another biofilm-reduced susceptibility could be contributed to the 
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slower growing rate or non-growing status of microbial cells in biofilm due to limited 
diffusion of oxygen, nutrients, or starvation. Slow growing or starved microorganisms are 
less susceptible to the action of antimicrobials [41]. There may also be increased stress 
responses which result in physiological changes that help protect the biofilm from 
environmental stresses [40]. 
Different strategies [26] to prevent or eradicate bacteria include: prevention of 
attachment by molecules through surface coatings that block adhesion via repressing 
expression of genes involved in adhesion and matrix production. Use signal inhibitors or 
within a biofilm, or some type of signal or chemical to cause release of cells back to their 
more susceptible planktonic state for exposure to antibodies and other antibiotics. 
Antibiofilm therapies based on incorporation of antibiotics into the medical materials 
have been reported [42-45]. Due to these many avenues of bacterial resistance towards 
antibiotics and through biofilm formation to enhance protection, a different approach to 
killing bacteria is warranted, especially in the nosocomial settings. A non-selective, safe, 
durable, controllable, coating that would kill bacteria and prevent biofilm formation 
should be investigated. One promising compound is Titanium dioxide, however alone 
requires photoactivation via long range ultra violet light which is not safe over time to 
humans. Exposure to long range ultra violet light can cause cancer in humans. Therefore, 
altering the Titania, or associating the Titania with something to cause it to be 
photocatalytically active in a coating format in visible light is investigated in this work. 
Titania or Titanium dioxide (TiO2), is a versatile non-selective compound with 
photocatalytic properties, degrades compounds through photo-oxidation. Titanium 
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dioxide exists in three different polymorphic lattice phases, Anatase, Brookite, and 
Rutile. Rutile phase is the most thermodynamically stable due to its minimal electrostatic 
repulsive energy; it is abridged in a linear structure with two of the twelve edges of the 
octahedron are shared [8]. Anatase phase shares four edges per octahedron without corner 
oxygen sharing.  Uniquely, Brookite phase is composed orthorhombically with three 
shared edges per octahedron. Zallen and Moret measured the optical absorption edge of 
Brookite Titania [9]. Extending throughout the visible light range, Brookite was observed 
to have a broad absorption edge in contrast to the steep absorption edges of Anatase and 
Rutile. In the evaluated spectral range, no evidence of a direct gap was observed. They 
propose the Brookite phase Titania is an indirect-gap semiconductor with an approximate 
bandgap of 1.9 eV [9]. In contrast, calculations using the self-consistent orthogonalized 
linear-combination-of-atomic-orbitals method, Mo and Ching, 1995 approximated a 
direct bandgap for Brookite [10]. Other researchers have determined that all three phases 
of Titania have similar direct bandgap energies (~3.1 + 0.1 eV) [11]. Banerjee and 
colleagues report the bandgap values for each phase is Anatase (3.2 eV), Rutile (3.02 
eV), and Brookite (2.96 eV) [12]. Whether direct or indirect, Brookite phase Titania 
exhibits the lowest bandgap energy. 
Chang and colleagues concluded that the optimal experimental conditions on 
degradation of salicylic acid were irradiation with intensity of 2.9mWcm−2 on at 
concentration of 250mgL−1 by both agitation and aeration processes (dissolved oxygen 
level = 8.2 mg O2 L−1) at pH 5 [57] achieving optimal hydroxyl radical yield of 5.1×10−17 
M. The pH, dissolved oxygen content, and irradiation intensity are important factors to 
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consider. Also the rate of recombination of hole–electron pairs is within nanoseconds 
[58-59]. Additives such as Pt, Pd and Au may improve the photocatalytic efficiency of 
TiO2 by slowing down the recombination of the hole-electron pair. Plus, a single photon 
can activate two oxygen molecules [58]. All of these parameters affect the photocatalytic 
efficiency of TiO2. 
Banerjee’s work used and Atomic Force Microscope (AFM) to visualize the 
antimicrobial photocatalytic activity of photo-activated Titania on bacteria [12]. They 
described the characteristics of a photocatalyst as its ability to simultaneously adsorb two 
reactants. Then efficiently adsorb light (hv > Eg) to reduce and oxidize the adsorbed 
reactants. The adsorbed light energy must be enough to excite the e- from the valence 
band to the conduction band producing an e--h+ pair. In the presence of water and 
dissolved oxygen (H2O/O2), the positive holes oxidize water splitting it into .OH and H+. 
The dissolved oxygen is reduced by the photo electron of the conduction band, generating 
superoxide anions (.O2-). H+ combines with the (.O2-) generating a hydroperoxyl radical, 
eventually producing a reactive oxygen species (ROS) H2O2 molecule. The photo 
induced ROS hydroxyl radical and hydrogen peroxide cause biocidal catalysis by 
penetrating cell walls and cutting DNA strands. The super oxide anion can enter the cell 
after oxidizing holes are made. Once inside, hydrogen peroxide and the super oxide anion 
may become hydroxyl radical precursors. Once inside the cell wall (Fe2+) may activate 
hydrogen peroxide via the Fenton reaction producing more damaging hydroxyl radicals. 
   Fe+2 + H2O2 → OH• + OH-1 + Fe+3 
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After the photocatalytic source is turned off, residual hydrogen peroxide within the cell 
would interact with the iron compounds generating additional hydroxyls also through the 
Fenton reaction. There is a second reaction pathway forming additional hydroxyl 
radicals. The Haber-Weiss iron-catalyzed reaction occurs when both H2O2 and superoxide 
ion are present [60-61]. 
Fe+3 + O2- → Fe+2 + O2 
Fe+2 + H2O2 → Fe+3 + OH- + OH•. 
Because the outer surface of the cell is the initial target of these reactive oxygen species 
(ROS), the chemical arrangements and rigidity of the each cell’s surface structure will 
determine the effectiveness of the photocatalytic activity of each type of Titania. 
The efficiency of the photocatalytic activity of Titania is also dependent on the 
surrounding environment. Phosphate ions from Phosphate Buffered Saline have a very 
high affinity for the Titania. Phosphate ions bind to the substrate surface causing the 
isoelectric point of the TiO2/aqueous interface to significantly shift downward to pH2.0 
and increasing the 3400cm-1 peak-intensity measured by vibrational sum-frequency 
spectroscopy (VSFS).  [62]. The isoelectric point was ~5.5 in the presence of Cl ions. 
However, the Langmuir binding constant of phosphate onto TiO2 at pH 2.3 is (3.8 + 0.8) 
x 104 dm3 mol-1 [63]. Adsorption kinetics depicting fast adsorption with very slow release 
confirmed that phosphate binds in a bidentate manner to Ti(IV) ions at the TiO2 surface 
[63].  
In commercial applications, hydrophobicity or hydrophilicity characteristics of a 
surface is important. A super-hydrophilic surface with a contact angle of <5o is used 
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commercially in antifogging and antifouling products and in self cleaning products [46]. 
The hydrophilicity of the surface could attract the hydrophilic heads of bacterial fimbriae. 
The fimbriae would attach to the surface where the hydroxyl radicals would successively 
attack the bacterial cell walls and membranes through the photocatalytic activity of the 
UVA or visible light (VL) irradiated surface. As Titanium dioxide water structure at the 
TiO2/aqueous interface is significantly dependent on the specific nature of the ions 
present in the diluent and the pH for optimized photocatalytic activity. 
 The type of coating chosen was made layer-by-layer and contained super-
hydrophilic surface characteristics. One component of the sub-coating, Poly(4-
styrenesulfonic acid) solution (PSS) (~75,000 Mw,  18%wt. in H2O, Sigma Aldrich, St. 
Louis, MO) has excellent film-forming and coating capabilities along with good 
conductive properties throughout an expansive range of relative humidity. The PSS 
polyelectrolyte is electroconductive and is used for antistatic resin in electrographic and 
electrophotographic substrates. It strongly interacts with electropositive active sites, and 
produces polyanions when it is dissolved in water. Due to the polyanionic nature of PSS, 
it has some tendency to also adsorb at the (100) crystal planes, but preferentially adsorbs 
to the {111) crystal planes of Brookite [64]. Charge and steric stabilization decrease 
coagulation effects in colloidal particles by these polyelectrolyte films.  The second 
component of the sub-coating was Poly(diallyldimethylammonium chloride) solution 
(PDDA) (average Mw 200,000-350,000, 20 wt. % in H2O, Sigma Aldrich, St. Louis, 
MO) a polyelectrolyte, PDDA, produces polycations when it is dissolved in water. It 
strongly interacts with electronegative active sites. PDDA contains Nitrogen molecules. 
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This work investigated two types of Brookite phase Titania, Br200 and BrNMP 
on a pH dependent polyelectrolyte sub-coating. They with be evaluated under UVA 365 
nm and Visible Light (VL) irradiation on Methyl orange (MO) photo-oxidation 
degradation. The hydrophilicity, surface chemical analysis via X-ray Photoelectron 
Spectroscopy (XPS), and X-ray Diffraction (XRD) of the Titania coatings will be 
characterized. The Titania coatings will be evaluated for the photo-oxidative biocidal 
effectiveness on Escherichia coli B.  
 
3.3 Results   
The chemical analyses of the PDDA/PSS (P) sub-coating surfaces with or without 
Titania nanoparticles and nanoparticle coatings confirm the presence of the sub-coating 
molecules and Titania on the surface (Table 1).  XPS spectra graphs of P or B sub-
coating with and without Br200, P25, BrNMP, vlp7000, Anatase, or vlp7001 are depicted 
in Appendix B. Surface elemental chemical analysis numerical results are exhibited in 
Table 1. 
The x-ray diffraction spectra of the glass cover slips with either P or Binder (B) 
sub-coatings with or without TiO2 nanoparticle coatings are depicted in Figures 2 and 3, 
respectively. The spectra graphs acquired were confirmed by comparison with the 
original spectra graphs from the nanoparticle powders that were used to make the 
coatings [65-66]. Kaewgun and colleagues reported considerably small (6-8mm) 
crystallite sized particles of their prepared Titania broadened the XRD peaks and 
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calculated phase composition of TiO2 from XRD data.  The Br200 (WACS-200) 
calculated phase composition was 45 wt% Anatase, 53 wt% Brookite, and 2 wt% Rutile. 
The P and B sub-coatings were different in surface hydrophilicity characteristics 
shown in Figure 4. The P coatings with or without various Titania depicted super-
hydrophilicity as the 10 µL drop of nanopure water instantly flattened out and 
disappeared from view with the naked eye. All P sub-coatings exhibited a contact angle 
measurement of < 1o. In contrast the B sub-coatings with or without various Titania 
displayed strong hydrophobic characteristics as the 10 µL drop of 18Ω nanopure water 
remained rounded. The B sub-coating alone exhibited a contact angle of 62.5o, B+P25 
51.5o, B+Br200 52.5o, B+BrNMP 67.5o, and B+vlp7000 at 105o indicating that the B sub-
coating is a material significantly more hydrophobic than the P sub-coating. For 
comparison, the hydrophilicity contact angle results are located in Table 3.  
 Significance of difference was evaluated with a student T-Test with an alpha of 
0.05. All P Sub-Coatings with or without all Types of Titania compared to all P Sub-
coatings with or without all Types of Titania at an alpha of 0.05 were not significantly 
different from each other (p=0.35). P Sub-Coating with or without all types of Titania are 
significantly different at an alpha of 0.05 from all B Sub-Coatings with or without all 
types of Titania with a range of p values from 2.36 x 10-5 to 6.93 x 10-6.  All B Sub-
Coatings with or without all Types of Titania compared to all B Sub-coatings with or 
without all Types of Titania at an alpha of 0.05 were all significantly different from each 
other (p=0.016 to 3.15 x 10-6). 
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The statistics of Figures 9 and 10 results were determined using a student T-Test 
with alpha equal to 0.05. E. coli B in PBS pH 7.4 or water at pH 7.4 exposed to UV light 
in the absence or presence of TiO2 P-25 or TiO2 Brookite did not significantly reduce the 
bacterial population in 120 minutes. In contrast, E. coli B in water at pH 4.0 exposed to 
UV in the presence of TiO2 P-25 and TiO2 Brookite had a significant seven log drop in 
120 (p=0.004) or 30 (p=0.001) minutes, respectively. E. coli B in the absence of TiO2 in 
water at pH 4.0 depicted no significant reduction of the bacterial population in 120 
minutes. The pH of the water at 120 minutes dropped from pH 7.4 to pH 6.0, while the 
water beginning at pH 4.0 remained at pH 4.0 (+ 0.2) throughout 120 minutes.  
The earlier version of the Free Suspension Bioassay [67], was on a large scale 
format. It is good and accurate, but used large amounts of materials, was labor intensive, 
and only one test variable could be evaluated at a time.  The assay was miniaturized with 
the option of two different assays in combination with a third. Dilution curves of E. coli 
B (n=8) were evaluated. Based on the results, the LIVE/DEAD® BacLight™ Bacterial 
Viability Kit (Molecular Probes®, Invitrogen™,USA) was found to be linear in the range 
of 1 x 103 to 1 x 108 CFU/mL in the presence of 1 mg/mL Titania. The second assay 
evaluated was the BacTiter-Glo™ Microbial Cell Viability Assay (Promega, Madison, 
WI). Based on the results, the BacTiter-Glo™ Microbial Cell Viability Assay was found 
to be linear in the range of 1 x 102 to 1 x 107 CFU/mL in the presence of 1 mg/mL 
Titania. 
 The six well – six mL volume free suspension assay was miniaturized to a 24 well 
format using a 1 mL volume assay. Many testing variables were tested at the same time 
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under this new assay format. An optically clear film was used to prevent evaporation 
during testing. After testing, 100 µL aliquots (n=4) from each sample well was dispensed 
into a 96 well black or white plate for fluorescence or luminescence assay, respectively. 
The 24 well testing assay in combination with either the fluorescent LIVE/DEAD® 
BacLight™ Bacterial Viability Kit or the luminescent BacTiter-Glo™ Microbial Cell 
Viability Assay provided excellent results after subtracting the background. Although, 
greater than the suggested cell concentration or greater than the suggested Titania 
concentration of 1 mg/mL gave erroneous or non-linear results with either assay.  
 The UVA generated photocatalytic activities of P25, Br200, or BrNMP Titania 
powder (1mg TiO2 / 1 mL) were evaluated by MO oxidative degradation as shown in 
Figure 5.  BrNMP and Br200 on P sub-coating completed the MO degradation in 10 and 
14 h, respectively.  BrNMP and Br200 on B sub-coating completed the MO degradation 
in 18 and 22 h, respectively. The commercial P25 on P sub-coat attained approximately 
80% degradation at 26 h and the P25 on B sub-coat achieved about 43% MO degradation 
at 26 h. The sub-coatings alone did not have much effect on MO degradation.  MO alone 
did not degrade and remained at 0%. 
 The Visible Light generated photocatalytic activities of the P or B sub-coatings 
alone or with P25, Br200, or BrNMP Titania coatings (2 mg TiO2 / 22 mm diameter 
cover slip) were evaluated by MO oxidative degradation as shown in Figure 6.  Titania 
coated onto the P sub-coat degraded the MO significantly faster than its counterpart on B 
sub-coating.  Br200 and BrNMP on P sub-coating completed the MO degradation in 12-
14 h. Br200 and BrNMP on B sub-coating completed the MO degradation in 16-18 h and 
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20 h, respectively. The commercial vlp7000 on P sub-coat attained approximately 95% 
degradation at 26 h and on B sub-coat it achieved about 55% MO degradation at 26 h. 
The sub-coatings alone had little effect on MO degradation.  MO alone did not degrade 
and remained at 0%. 
The UVA generated photocatalytic activities of the P or B sub-coatings alone or 
with P25, Br200, or BrNMP Titania coatings (2mg TiO2 / 38mm2 cover slip) were 
evaluated by MO oxidative degradation as shown in Figure 5.  All Titania coated onto the 
P sub-coat degraded the MO significantly faster than its counterpart on B sub-coating.  
BrNMP and Br200 on P sub-coating completed the MO degradation in 10 and 14 h, 
respectively.  BrNMP and Br200 on B sub-coating completed the MO degradation in 18 
and 22 h, respectively. The commercial P25 on P sub-coat attained approximately 80% 
degradation at 26 h and the P25 on B sub-coat achieved about 43% MO degradation at 26 
h. The sub-coatings alone did not have much effect on MO degradation.  MO alone did 
not degrade and remained at 0%. Statistics were determined using a student T-Test with 
alpha equal to 0.05. P or B Sub-Coating with MO (20 µM) in water at pH 4.0 exposed to 
UV light (365nm) with a (363-364 µW/cm2) intensity in with or without P- P-25 26+ h 
and P-Br200 14 h, or P-BrNMP 10 h, B- P-25 28+ h and B-Br200 22 h, or B-BrNMP 18 
h oxidative degradation of MO. Br200 and BrNMP were significantly different from 2 h -
26 h (p= 0.02 – 0.005); P25 was significantly different from16 h-28 h (0.044 – 0.032).  
MO alone or on P or B- Sub-Coating was not significantly different throughout the 26 h 
evaluated (p=0.35). 
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The Visible Light generated photocatalytic activities of the P or B sub-coatings 
alone or with P25, Br200, or BrNMP Titania coatings (2 mg TiO2 / 22 mm diameter 
cover slip) were evaluated by MO oxidative degradation as shown in Figure 6.  Titania 
coated onto the P sub-coat degraded the MO significantly faster than its counterpart on B 
sub-coating.  Br200 and BrNMP on P sub-coating completed the MO degradation in 12-
14 h. Br200 and BrNMP on B sub-coating completed the MO degradation in 16-18 h and 
20 h, respectively. The commercial vlp7000 on P sub-coat attained approximately 95% 
degradation at 26 h and on B sub-coat it achieved about 55% MO degradation at 26 h. 
The sub-coatings alone had little effect on MO degradation.  MO alone did not degrade 
and remained at 0%. Percent survival of E. coli B (EC) CFU/mL with and without VLP 
7000, Br200, and BrNMP Titania on B Sub-Coating exposed to a cool white 8 Watt bulb 
for either 0, 1, 2, 4, 6, 8, 10, 20, 30, 40, 50, or 60 minutes or the dark for 0, 30, or 60 
minutes. (Error bars may be too small to see.) 
Student T-Test indicated significant difference at an alpha of 0.05 between EC at 
0 min to vlp7000, not significantly different at 0  or 10 min VL or 30 – 60 min D; 
significantly different at 20 – 60 min VL (p= 0.005 – 0.001); between EC at 0 min to  
Br200, not significantly different at 0, 2, 4, or 6, min VL or 30 – 60 min D (p= 0.3 – 0.2), 
but significantly different at 8 – 60 min VL (p= 0.01 – 0.0002); and between EC at 0 min 
to BrNMP, not significantly different at 0 min VL or 30 – 60 min D, but significantly 
different at 10 – 60 min VL (p= 0.04 – 0.0002).  
Preliminary studies were performed with Titania in modified, miniaturized free 
suspension assays to determine a starting concentration of Titania for the coating studies. 
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Dilution curves indicate linear results with minimal background in the 103 to 108 
CFU/mL range using the Live/Dead®  BacLight™ Bacterial Viability fluorescent based 
Assay (L-7012, Molecular Probes, Eugene, OR) as shown in Figure 7. 
Evaluation of the second assay dilution curve results indicate linearity with minimal 
background in the 102 to 107 CFU/mL range using the Luminescent Assay Bac Titer-
Glo™ Microbial Cell Viability Assay (Promega: Madison, WI, USA) depicted in Figure 
8.  
Effects of UVA activated P25, Br200 and BrNMP Titania 1 mg/mL using the 
miniaturized free suspension on E. coli B (EC) with the BacLight ™Assay over a 2 h 
time period were evaluated (Figure 12). Results indicated that Br200 yielded an 8 log 
drop in 30 minutes. BrNMP and P25 required 2 h to yield the 8 log drop. P25 in the dark 
incurred an approximate 0.5 log drop during the 2 h, while Br200, BrNMP, and EC in 
both UVA and dark remained the same.  
Evaluation of the lower count (1 x 104) bacteria using either the Spiral Plater or 
manual cell spreading yielded a 4 log drop in 60 or 90 seconds with P25 and Br200, 
respectively (Figure 13). EC in both UV and Dark along with P25 and Br200 in the dark 
results yielded the same as time zero. Student T-Test indicated significant difference at an 
alpha of 0.05 between EC at 0 sec to P25, not significantly different at 0, or 90-120 sec in 
the dark, but significantly different at 30 – 120 sec in UVA (p= 0.004 – 0.002); between 
EC at 0 min sec to  Br200, not significantly different at 0 min UVA or 90 - 120 sec D or 
at 30 sec in UVA; but significantly different at 60 – 120 sec in UVA  (p= 0.006 – 0.002). 
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The effects of visible light (VL) activated Br200, BrNMP, or vlp7000 Titania 
nanoparticles on EC were evaluated as shown in Figure 14. Br200 results yielded a 4 log 
drop in EC within 30 minutes; vlp7000 completed the 4 log drop in 60 minutes while 
BrNMP results yielded a ~2.5 log drop in 60 minutes.  EC under light or in the dark, 
Br200, BrNMP, and vlp7000 with EC cultures in the dark remained viable. 
The results of exposing free suspension Titania nanoparticles (VLP 7000, Br200, 
and BrNMP) to visible light using a fluorescent 8 Watt cool white bulb at 100 µW/cm2 
intensity on E. coli B for 0, 10, 20, 30, 40, 50, or 60 minutes yielded the results shown in 
Figure X. Dark measurements were also recorded at 0, 30, and 60 minutes. Three 
separate experiments were performed in triplicate with the results normalized in a percent 
survival curve and recorded.   
Br200 EC under visible light dropped to zero percent alive within 30 minutes for 
all experiments and within 20 minutes for two of the three experiments.  VLP7000 EC 
and BrNMP EC dropped to 0% within 60 minutes for two of the three experiments. 
Student T-Tests were performed with an alpha of 0.05. At zero minutes all 
variables were not significantly different and results were normalized at 100%.  At ten 
minutes of exposure to visible light Br200 EC (51%) and BrNMP EC (59%) were 
significantly different to EC alone (88%) with p values of 0.0014 and 0.0001, 
respectively. VLP700 EC dropped to 79%. VLP7000 EC was significantly different to 
Br200 EC (p=0.0275). Other variables were not significantly different at 10 minutes.  At 
20 minutes exposure, Br200 EC (13%) and BrNMP EC (54%) were significantly 
different to EC alone (78%) with p values of 0.0016 and 0.0214, respectively. VLP7000 
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EC (65%) was significantly different to Br200 EC (p=0.0105).  Br200 EC was 
significantly different to BrNMP EC (p=0.0003). Other variables were not significantly 
different at 20 minutes.  At 30 minutes exposure to visible light, VLP7000 EC (54%), 
Br200 EC (0%) and BrNMP EC (52%) were significantly different to EC alone (88%) 
with p values of 0.0109, 3.9x10-6 and 0.0009, respectively. VLP7000 EC was 
significantly different to Br200 EC (p=0.0001).  Br200 EC was significantly different to 
BrNMP EC (p=3.06x10-6). Other variables were not significantly different at 30 minutes.  
At 40 minutes exposure to visible light, VLP7000 EC (38%), Br200 EC (0%) and 
BrNMP EC (53%) were significantly different to EC alone (75%) with p values of 
0.0001, 1.4x10-6 and 0.0296, respectively. VLP7000 EC was significantly different to 
Br200 EC (p=0.0004).  Br200 EC was significantly different to BrNMP EC (p=2.69x10-
5). Other variables were not significantly different at 40 minutes.  At 50 minutes exposure 
to visible light, VLP7000 EC (22%), Br200 EC (0%) and BrNMP EC (45%) were 
significantly different to EC alone (80%) with p values of 0.0007, 1.92x10-8 and 0.0024, 
respectively. VLP7000 EC was significantly different to Br200 EC (p=0.0365) and 
BrNMP EC (p=0.0056).  Br200 EC was significantly different to BrNMP EC (p=0.0003). 
At 60 minutes exposure to visible light, VLP7000 EC (2.7%), Br200 EC (0%) and 
BrNMP EC (10%) were significantly different to EC alone (65%) with p values of 
4.36x10-5, 2.86x10-8 and 0.0006, respectively. Other variables with visible light exposure 
were not significantly different at 60 minutes.    
 EC alone samples that remained in the dark throughout 30 (98%) or 60 minutes 
(103%) were not significantly different from EC alone (100%) at zero minutes. VLP7000 
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EC was significantly different at both 30 (77%) and 60 minutes (66%) when compared to 
it zero time point (100%) with p values of 0.0237 and 0.0145 respectively. Br200 EC was 
not significantly different to the zero time point (100%) from either the 30 (95%) or 60 
minute (95%) time points. BrNMP EC was significantly different to the 30 (80%) and 60 
minute (80%) time points with p values of 6.78x10-5 and 0.0056, respectively. 
 Comparing EC alone under visible light at 30 minutes (88%) to EC alone in the 
dark 30 minutes (98%) was significantly different with a p value of 0.0333. EC alone at 
60 minutes comparing visible light (65%) to dark (103%) exposure was also significantly 
different (p=0.0042).  VLP EC at 60 minutes comparing visible light (2.7%) to dark 
(66%) exposure was significantly different (p=0.0013).  Comparing Br200 EC under 
visible light at 30 minutes (0%) to Br200 EC in the dark at 30 minutes (95%) was 
significantly different with a p value of 9.996x10-9. Br200 EC at 60 minutes comparing 
visible light (0%) to dark (95%) exposure was also significantly different (p=2.48x10-8). 
Comparing BrNMP EC under visible light at 30 minutes (52%) to BrNMP EC in the dark 
at 30 minutes (80%) was significantly different with a p value of 0.0002. BrNMP EC at 
60 minutes comparing visible light (10%) to dark (80%) exposure was also significantly 
different (p=0.0003). Br200 results indicated a much stronger killing capability than 
either VLP7000 or BrNMP under visible light. 
P or B sub-coatings with or without Br200, BrNMP, or P25 Titania (2mg/38mm2 
surface) were evaluated every 10 minutes under UVA irradiation for 0-60 minutes. 
Depicted in Figure 15, are the photocatalytic activity results with the P sub-coating. 
Br200, P25, and BrNMP results yielded a 4 log drop in viable cells within 30, 40, or 50 
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minutes, respectively. EC alone or on the P sub-coating exposed to UVA remained 
viable. All samples exposed to the dark for 1 h remained viable. Student T-Test indicated 
significant difference at an alpha of 0.05 between EC at 0 min to P25, not significantly 
different at 0 or 10 min UVA; significantly different at 20 – 60 min VL (p= 2.5 x 10-5 – 
1.3 x 10-6), and at 30 – 60 min D (p= 0.039 – 0.002); between EC at 0 min to  Br200, not 
significantly different at 0  or 10 min UVA or 30 – 60 min D (p= 0.3 – 0.2), but 
significantly different at 20 – 60 min UVA (p= 5 x 10-4 – 1. X 10-6); and between EC at 0 
min to BrNMP, not significantly different at 0 or 10 min UVA, or 30 – 60 min D, but 
significantly different at 20 – 60 min UVA (p= 0.001 – 1.3 x 10-6). 
Figure 16 shows the results of the UVA activation (365 nm, 363-364 µW/cm2) of 
Br200, BrNMP, or P25 on the B sub-coating. Br200 killed the total EC with a 4 log drop 
in 40 minutes. BrNMP or P25 completely reduced the viable count to 0 at 50 and 60 
minutes, respectively. Binder under UVA irradiation and P25 in the dark reduced the cell 
population by ~20%. EC alone and all variable dark exposed samples except P25 in the 
dark maintained the viable population of cells. Student T-Test indicated significant 
difference at an alpha of 0.05 between EC at 0 min to P25, not significantly different at 0 
min UVA; significantly different at 10 – 60 min UVA (p= 0.01 – 0.001), and at 30 – 60 
min D (p= 0.04– 0.002); between EC at 0 min to  Br200, not significantly different at 0 
min UVA  or 30 – 60 min D (p= 0.3 – 0.2), but significantly different at 10 – 60 min 
UVA (p= 0.001 – 0.01); and between EC at 0 min to BrNMP, not significantly different 
at 0 min UVA or 60 min D, but significantly different at 10 – 60 min UVA (p= 0.04 – 
0.001), or 30 min D (p= 0.01). 
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P or B sub-coatings with or without Br200, BrNMP, or vlp7000 Titania 
(2mg/38mm2 surface) were evaluated every 10 minutes under VL (Cool White 8 Watt 
lamp, 0.1mW/cm2) for 0-60 minutes (Figures 17 and 18). Additionally, Br200 was tested 
at 0, 1, 2, 4, 6, 8, and 10 minutes separately with the proper controls to determine the 
survival curve. Depicted in Figure 17, are the photocatalytic activity results using the P 
sub-coating. Br200, BrNMP, and vlp7000 results yielded a 4 log drop in viable cells 
within 8, 30, or 40 minutes, respectively. EC alone or EC on the P sub-coating exposed to 
VL irradiation remained viable. All samples exposed to the dark for 1 h remained viable. 
Student T-Test indicated significant difference at an alpha of 0.05 between EC at 0 min to 
P25, not significantly different at 0 min VL or 30 – 60 min D; significantly different at 10 
– 60 min VL (p= 0.01 – 0.003); between EC at 0 min to  Br200, not significantly 
different at 0, 2, 4, or 6 min VL or 30 – 60 min D (p= 0.3 – 0.2), but significantly 
different at 8 – 60 min VL (p= 0.002 – 4 x 0-11); and between EC at 0 min to BrNMP, not 
significantly different at 0 min VL or 30 – 60 min D, but significantly different at 10 – 60 
min VL (p= 0.02 – 0.002). 
Figure 18 shows the results of the VL activation of Br200, BrNMP, or vlp7000 on 
the B sub-coating. Br200 killed the total EC with a 4 log drop in 40 minutes. BrNMP or 
vlp7000 completely reduced the viable count to 0 at 50 or 60 minutes, respectively. 
Binder under VL irradiation reduced the cell population by ~20%. EC alone exposed to 
VL and all variable samples in the dark maintained the viable population of cells. Student 
T-Test indicated significant difference at an alpha of 0.05 between EC at 0 min to 
vlp7000, not significantly different at 0  or 10 min VL or 30 – 60 min D; significantly 
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different at 20 – 60 min VL (p= 0.005 – 0.001); between EC at 0 min to  Br200, not 
significantly different at 0, 2, 4, or 6, min VL or 30 – 60 min D (p= 0.3 – 0.2), but 
significantly different at 8 – 60 min VL (p= 0.01 – 0.0002); and between EC at 0 min to 
BrNMP, not significantly different at 0 min VL or 30 – 60 min D, but significantly 
different at 10 – 60 min VL (p= 0.04 – 0.0002).  
 
3.4 Discussion  
X-ray Photoelectron Spectroscopy (XPS) verified that Titanium molecules were 
present on the surface of the coatings, allowing the Titania to have direct contact with the 
organic substance to be oxidatively degraded. TiO2 P-25 was free of Cl 2p while Brookite 
contained 2.31% mass concentration. This may have contributed to the increased 
oxidative efficacy of the Brookite. Both contained small amounts C 1s which may have 
come from atmospheric pressure rather than as a consequence of the precursor [62]. 
X-ray Diffraction (XRD) confirmed the peaks of Br200 and BrNMP to the 
original powder sample peaks [66, 68].  This verified that the Br200 and BrNMP Titania 
coatings should have the same percent of TiO2 phases meaning the specific type of 
crystal lattice structure contained within each sample as the nanoparticle powders with 
approximately 44-45% Anatase, 53% Brookite, and 2-3% Rutile.  
Low temperature calcination of 200oC for 2 h on both Br200 and BrNMP Titania 
produced crystallite sizes ranging from 5-8 nm, therefore, providing a very high surface 
area ranging from (BET) 138 - 157 m2/g [65]. This provides a significantly greater 
surface area per particle than the Degussa commercial P25 reference standard at (BET) 
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56 m2/g with 79% Anatase and 21% Rutile phase TiO2. The Kronos vlp7000 has an 
approximate 15 nm crystallite size with a surface area of (BET) 225 m2/g and a stable 
working pH range of 4 – 9. The Kronos vlp7000 has a much larger surface area than the 
Brookite samples. The crystal lattice structure of Br200 and BrNMP contains Brookite 
phase which is orthorhombic and Anatase phase which is tetragonal. Kaewgun and 
colleagues proposed that the mixture of orthorhombic phase and tetragonal phase in 
Br200 or BrNMP caused a slower electron/hole recombination due to the transfer 
between the two phases of crystallites [69]. Even though the Kronos vlp7000 has a much 
larger surface area of (BET) 225 m2/g than the polymorphic Brookite (BET) 157 m2/g 
[66], it is made with pure Anatase and the single phase product may contribute to a faster 
electron/hole recombination, decreasing the photocatalytic efficiency.  
The two different sub-coatings displayed different hydrophilic properties. The P 
sub-coating exhibited extreme hydrophilic surfaces as shown in Figure 4, while the B 
sub-coatings exhibited hydrophobic surfaces. The P coatings contained strong 
polyelectrolytes and were rinsed in neutral pH nanopure 18Ω water between each layer 
and after completion. In contrast, the B sub-coating is finalized at pH3. The surface tack 
and surface gloss were both observed to be low in the P sub-coating and both were 
observed to be high in the B sub-coating. After the liquid phase deposition of the Titania 
followed by air drying, the surface gloss of the P sub-coating remained lower than the 
surface gloss of the B sub-coating. Bacteria are attracted to the hydrophilic surface of the 
P sub-coatings with Titania. Therefore the bacteria can interact more quickly with the 
Titania and its free radicals causing oxidative death more quickly. The hydrophobicity of 
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the B sub-coating can repel the negative charge of the bacteria. This could be the factor 
that causes the P sub-coating to provide faster killing. The distance and orientation of the 
bacteria to the active sites of the Titania are also factors affecting the photocatalytic 
activity. 
Other considerations that may increase the enhancement effect of the P sub-
coating over the B sub-coating include the following.  According to mindat.org, it was 
named for Henry James Brooke (1771-1857), who was an English crystallographer and 
mineralogist. The length of edges on the orthorhombic crystallite of Brookite phase 
Titania are, a=5.4558 Å, b=9.1819 Å, and c= 5.1429 Å, where 1 nm = 10 Å [70].  The 
OHBA crystal structure site labeled the Brookite Space group as Pbca and the Pearson 
symbol as oP24 [71].  OHBA reported that it contains approximately two atoms thick 
with four layers on one edge, boding well for surface adsorption of N and S. Because the 
crystallite particle sizes are 5-8 nm in diameter, bulk properties break down, surface area 
and surface tension to volume significantly increases causing surface effects to dictate 
properties [71].  Light absorption and re-emission properties change. Due to ionic 
bonding, the ion size of the Sulfur in either the +4 state (0.37 Å), or the +6 state (0.29 Å) 
or ion size of the Nitrogen in either the +3 state (0.16 Å) or the +5 state (0.13 Å), 
indicates that either one could easily adsorb to the surface [72]. This would aid in 
broadening the absorption edge, narrowing the band-gap, causing the photocatalytic 
activity of Br200 and BrNMP to significantly increase.  
 Buffer composition and pH play a strong role in the oxidative ability of TiO2 to 
kill bacteria. The PBS contained phosphate anions which strongly adsorb to TiO2 forming 
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bidentate complexes, shifting the isoelectric point down towards pH 2.0 [62, 73-74].  
This may have caused a lack of adjacent sites to the oxide, hence, preventing the 
formation of tetrahedrally coordinated water. pH values below the isoelectric point of the 
TiO2 may possibly flip the water dipoles [62]. The TiO2 in water at pH 4.0 proved to 
have more efficient results in killing the bacteria than pH 7.4 whether in water or PBS. 
These results indicate that photocatalytically activated TiO2 P-25 or Brookite at pH 4.0, 
optimum pH and diluent, can provide a non-selective modality for decreasing the 
transmission of pathogenic bacteria 
MO oxidative degradation occurred in significantly less time with the Br200 and 
BrNMP Titania on either the P or B sub-coatings than the commercial P25 or vlp7000 
Titania. Both the Br200 and BrNMP Titania on the P sub-coating was significantly faster 
than the B sub-coating to complete the MO degradation by 2 – 4 h under both UVA and 
VL irradiation. Neither P nor B sub-coating alone significantly degraded MO over the 26 
h time period. 
Using the BacLight™ Assay, UVA irradiation on suspended Br200 Titania was 
90 minutes faster than BrNMP, or P25 Titania in AW. While in the lower cell population, 
enumerating with viable cell counts, the commercial P25 was faster by 30 seconds at 
completing the 4 log kill of cells than Br200.  That was the first time in this study that the 
commercial P25 was faster than Br200.  
Evaluating the effects of VL irradiation to photocatalytically activate the 
suspended Br200, BrNMP or vlp7000 Titania on bacterial killing resulted in Br200 
displaying a complete elimination of viable bacteria within 30 minutes. P25 Titania 
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required twice the amount of time and BrNMP did not complete the elimination in the 60 
minute time period. 
Br200 Titania on either P or B sub-coating, with either UVA or VL irradiation 
eliminated all viable cells from 10 – 22 minutes faster than the next fastest Titania type. 
With either UVA or VL irradiation, Br200, BrNMP, and P25 (UVA) or vlp7000 (VL) on 
the P sub-coating averaged total elimination of viable cells 10 minutes faster than with 
the Titania on the B sub-coating. VL irradiation (0.1mW/cm2) activated all appropriate 
types of Titania equally or better than UVA irradiation at 363-364 µW/cm2 on 
appropriate Titania samples.  
3.5 Conclusions  
Light intensity, wavelength, surface material characteristics, pH, band gap, 
efficiency of hole-electron recombination, amount of dissolved oxygen, broad edge 
(indirect bandgap) versus sharp edge (direct bandgap), number of available active surface 
sites, and bacterial load affect efficiency of photo-oxidation. Based on the results 
obtained in this study, Br200 Titania on the P Sub-Coating provided superior oxidative 
activity on both MO degradation and EC bacterial killing. One explanation is reported by 
Zallen and Moret, 2006. At ambient temperature, natural Brookite TiO2 crystals were 
examined via optical-absorption ranging from 2.1 to 3.54 eV.  The Brookite TiO2  
absorption edge is broad, continuing throughout the visible range with no direct gap [9].  
In contrast to tetragonal forms, the orthorhombic structure encompasses a larger range of 
bond lengths from the six unique nearest-neighbor Ti-O bond lengths. They suggest that 
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Brookite TiO2 is an indirect-gap semiconductor with a bandgap approximating 1.9 eV 
[9].  
The low temperature method in which the Br200 or BrNMP were formed and 
calcined, produced small crystallite sizes ranging from 5 – 8 nm in diameter, and a large 
surface area, approximately (BET) 157 m2/g  [66].  The monolith bulk properties give 
way to surface effect characteristics as the crystallites are four layers on one edge and 
two atoms thick enabling N and S surface adsorption [70-72]. This large surface area 
would provide more opportunities for contact with molecules.  The smaller crystallite 
sizes allow for more particles to make up a specific mass, hence providing more surface 
area due to higher numbers of particles. vlp7000 contains a larger surface area to volume 
ratio of (BET) 225 m2/g than Brookite. Therefore, the higher activities of the Br200 or 
BrNMP may be from the polymorphic composition in the combination of Brookite and 
Anatase. This combination may cause the electron/holes to recombine more slowly since 
the electrons must travel from one type of lattice structure to a different type of lattice 
structure, while vlp7000, made of pure Anatase, produced efficient electron/hole 
recombination. Thus, the Br200 and BrNMP in conjunction with the P sub-coating were 
superior to vlp7000 in visible light. 
Based on our results, Br200 on P Sub-Coating consistently had stronger 
photocatalytic activity than BrNMP on P or B Sub-Coating. Theory suggested it should 
have been the opposite since BrNMP is associated with a Nitrogen containing compound, 
N-methylpyrrolidone at 168oCelsius for 4 h (4g/200mL) as described in [65]. Charred 
organic residue of NMP remaining on the surface covered up or was bound to active sites 
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on the Brookite, providing less photocatalytically active sites to oxidize bacteria. It was 
found that temperatures of 420oC were required to remove all of the extraneous NMP, 
and these high temperatures caused phase changes to a more Anatase product and 
sintering which caused reduction in surface area to volume ratio, decreasing the 
photocatalytic activity [68]. Since bacteria are much larger than the Titania crystal 
particles whether in suspension or bound onto a surface, distance and orientation effects 
would be more pronounced for bacteria than for Methyl orange [61].  
Also one may propose that the hydrophobic nature of the B Sub-coating may have 
delayed the BrNMP activity, but all samples were exposed to the B Sub-coating and 
Br200 was more active than BrNMP, again due to residual charred organic residue and 
blockage of potential photocatalytic active sites.  However, each Titania on the P coating 
performed complete biocidal killing 10 minutes faster than its counterpart on the B Sub-
coating.  This may be the difference in the effect of the P Sub-coating super-
hydrophilicity attracting the bacteria versus the B Sub-coating hydrophobic 
characteristics repelling the bacteria. The P sub-coating containing N and S molecules in 
different ionic states, through surface interaction affect the Titania. These effects 
lengthened the absorption edge into the visible range, narrowed the band-gap, thereby 
increasing the photocatalytic activity of the Titania. 
Br200 results indicate that it has a stable pH working range that includes pH 3-4. 
The B sub-coating has a pH of 3 and the AW that was used in the experiments was at pH 
of ~4. The super hydrophilic surface characteristics of the P sub-coating aid in attracting 
the bacteria to adhere while hydrophobic coatings may even repel the bacteria somewhat.  
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EC and many other species of bacteria contain hydrophilic fimbriae that attach to biotic 
and abiotic surfaces [31-32].   
 After the bacteria adhere to the surface of the photocatalytically activated Br200 
Titania surface, bacterial death ensues via two main mechanisms. First, consecutive 
oxidative attacks to the cell wall / membrane via the hydroxyl radical (HO-)  [75] 
destabilize the cell wall. Secondly, the oxygen located on the TiO2 surface can act in its 
molecular form as an electron acceptor in the superoxide anion radical form. When the 
adhered bacteria have direct contact with the photo-generated holes, their cell walls / 
membranes are further destabilized and decomposition ensues via irreversible loss of 
electrons and direct bond disruption at the TiO2 surface [75-77]. After the cell wall is 
disrupted, the presence of superoxide anions and hydrogen peroxide, the Fenton and 
Haber-Weiss Reactions continue to produce hydroxyl radicals inside the bacteria, 
oxidizing the DNA. Chen and colleagues observed a correlation between the 
decomposition of bacteria and organics such as MO [78].  Therefore, based on this 
research, P sub-coatings with Br200 Titania displays a superior non-selective method of 
killing bacteria. This novel P Sub-Coating with bound Br200 Titania could provide non-
selective surface coatings in the hospital, surgical, and long term care arenas to aid in 
prevention of transmission of pathogens and prevention of biofilm formation. In fact, 
because this coating is turned “on” when light is on (10-9 seconds) [59], and turned “off” 
when light is off, it could be used in many nosocomial settings, community settings, and 
on appliances, cars, and a vast number of other surfaces.  
 66 
 This work provided new evidence of low temperature association between the P 
sub-coating molecules and surface characteristic effects of the Titania showing superior 
photocatalytic activity on MO degradation and bactericidal properties. 
 
3.6 Experimental 
Titanium dioxide Br200 and BrNMP nanoparticles samples were generously 
given to our lab by Dr. B. I. Lee and Dr. S. Kaewgun of Clemson University. Br200 
nanoparticles were made by the WACS process as described in [66]. This sample was 
calcined at 200oCelsius for 2 hours (h) in air. SACS-NMP (BrNMP) was made by the 
WACS process with a SACS post treatment carried out in N-methylpyrrolidone at 
168oCelsius for 4 h (4g/200mL) as described in [65]. This BrNMP sample was calcined 
in air at 200oCelsius for 2 h. For the long wave ultraviolet light (UVA) (365nm) 
comparisons, the commercial TiO2, P25 from Degussa, (Evonik Industries AG, Germany) 
was used. For the Visible Light comparisons, the commercial Kronos vlp7000 
(KRONOS, Inc., Dallas, TX) was used.  
A super hydrophilic layer-by-layer (LBL) polyelectrolyte sub-coating using 0.1M 
Poly (diallyldimethylammonium chloride) (PDDA) and 0.1M Poly(styrenesulfonic acid) 
in nanopure water, separately, modifying the method from Tsuge et al. 2008 [79]. PDDA, 
Mw ~200,000–350,000, 20 wt.% aqueous solution), and PSS, Mw ~75,000, 18 wt.% 
aqueous solution) were purchased from Sigma-Aldrich. Due to the strong polyelectrolytic 
nature of PDDA and PSS, the pH was not adjusted. 
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At ambient room temperature #2 micro-cover-glass slips (22 mm diameter) 
(Electron Microscopy Sciences, Hatfield, PA) were prepared to receive the 
polyelectrolytes via Tsuge et al. 2008 method [79].  The 25-LBL coatings were made 
beginning with PDDA and ending with PSS and air dried. In this publication, the 
PDDA/PSS sub-coated slides will be labeled P. Another binder graciously provided by 
Dr. B.I. Lee was used, GPTS:TEOS (5:3) with HNO3 and EtOH at pH = 3 to compare 
and test the effectiveness of the two sub-coatings.  Aliquots (50 µL) of the binder (B) was 
deposited onto the glass cover slips and air dried. The glass cover slips sub-coated with 
either P or B were placed on a clean baking sheet.  
 Five mol of 3-glycidoxypropyl-trimethoxysilane (Gelest) was mixed with 3 mol 
of Tetramethyl orthosilicate (Alfa Aesar). Ethanol prehydrolyzed the solution (Alfa 
Aesar) at room temperature with constant stirring for 3h. Nitric acid was added to bring 
the pH to 3. Two aliquots of 50 µL of Binder were aseptically pipetted onto sterile glass 
cover slips with drying at room temperature in between. Then the coated slides were 
aseptically stored in a 24 well plate for further use. 
Each Titania, Br200, Br-NMP, P25, or vlp7000 was mixed into nanopure water 
containing 2mL of 0.1M HCl per 100mL of water pH ~4.  The acidic water is referred to 
as AW. The final Titania concentration was 6.67mg Titania/mL water. The liquid Titania 
suspensions were sonicated (Sonicator FS30H; Fisher Scientific) for 1 h and vortexed.  
Each sub-coated cover slip received 2 aliquots of 150 µL of Br200, Br-NMP, P25, or 
vlp7000 suspension, (2mg/38mm2) with ambient air drying between aliquots. The Titania 
cover-slips were heated in a toaster oven at 60oC for 1 h prior to use. 
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X-ray Photoelectron Spectroscopy (XPS) (Axis 165, Kratos; 20mA, Anode HT 
(12kV) was performed on the P sub-coating with and without Titania (pass energy of 40 
with 0.5eV step, 120ms-dwell time and 3 sweeps per sample).  Both general and high-
resolution scans were performed.  The XPS evaluation will identify elements on the 
surface of the sample.  An X-ray powder diffractometer was used to determine phase 
composition and crystallite size of the TiO2 samples using a Rigaku ULTIMA IV with 
CuKα  radiation at 1.5418 Å, continuous scans with a sampling width of 0.020° over a 
range of 20 to 350 (2θ). Hydrophilicity was determined by dropping 10 µL of nanopure 
water onto the surface of the coating. A close up picture was taken from the direct side 
view for evaluation of the hydrophilic properties of each surface. 
Contact angle of a surface will identify the wet-ability of a surface as shown in 
Figure 2. A hydrophilic surface is more difficult for hydrophobic walled bacteria to 
attach, therefore, decreasing bacterial attachment and biofilm formation. Using a macro-
digital camera, we will determine the hydrophobic/hydrophilic characteristics of each 
sample’s surface via contact angle measurement. Each coating type will receive a 10 µL 
drop of 18 Ω nanopure water. 
 Assuming a spherical or ellipsoid liquid droplet surrounded by gas resting on a 
solid surface, we will measure the hydrophilicity of the surface on our samples (n=4). 
Using a high resolution micro-lens camera, pictures will be taken of the three phase 
boundary where the liquid, gas, and solid intersect. The contact angle, θC, is the angle 
formed by a liquid at this three phase boundary and can be expressed by Young’s 
Relation depicted in Figure 11 and Equation 1 below. 
 69 
         (1)   
 
 
Where:   = Interfacial tension between the solid and gas    
  
      = Interfacial tension between the solid and liquid     
 
   = Interfacial tension between the liquid and gas 
 
The B or P sub-coatings with or without Br200, Br-NMP, P25, or VLP7000 
Titania were evaluated for photocatalytic activity. An empty well with Methyl Orange 
(MO) was used for the control. A multiple ray lamp (MRL, Model 58; Fisher Scientific) 
with different 8 Watt tubes UVA (365nm) at 363-364 µW/cm2) and visible light (Cool 
White) at 0.100 mW/cm2) was utilized as the source for photoactivation.  The intensity of 
light was verified with a UVX Digital Radiometer, (Model-UVX, UVP, Inc., Upland, 
CA) and an ACCU- CAL-50-V (Dymax Corporation, CT) for UVA and visible light, 
respectively. Polystyrene plates (24-well) containing the Titania coated cover slips were 
secured onto a microplate orbital mixer (Microplate Genie, Model SI-0400, VWR).  One 
milliliter of 20 µM MO solution was added to each well. A non-fluorescing optically 
clear film (TemPlate® RT Optical Film, 2978-2700, USA Scientific, Inc.) was adhered to 
the polystyrene plate to prevent evaporation of the MO. The lamp intensity was adjusted 
to accommodate the film.  
Uniform samples were removed at 2 h intervals (0-26 h). Each sample containing 
Titania was filtered through a Puradisc™ 25 AS Disposable Filter Device with a 0.2 µm 
Polyethersulfone Membrane (Whatman, USA) to remove any possible free Titania, and 
to prevent false positive absorbance via scattering. Quantitative spectral results were 
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obtained with a Genesys 20 Thermo Spectronic spectrophotometer at 490 nm (Model 
4001/4, Thermo Scientific, USA). The percent of MO oxidative degradation, D, was 
plotted against time in hours shown in Equation 2, where A0 is the initial peak intensity at 
490 nm, and A is the instantaneous peak intensity at 490 nm. 
                     (2) 
Escherichia coli B (E. coli B) (ATCC 11303, Manassas, VA) was purchased from 
the American Tissue Culture Collection (ATCC).  Cultures incubated in Tryptic Soy 
Broth (TSB) for 12-14 h in an Environmental Incubator Shaker (Model G24, New 
Brunswick Scientific) were harvested and centrifuged at 7,000 x g in a microcentrifuge 
(Eppendorf Centrifuge, Model 5417R). Stock cultures of E. coli B were frozen in TSP + 
5% Glycerol and stored at -80oC till further use. 
Because Phosphate has a very high affinity to TiO2, acidic sterile water (AW) at 
~pH4 (2mL of 0.1M HCl / 100mL water) was used for these assays instead of Phosphate 
Buffered Saline. Cells were washed three times in AW with centrifugation. Upon re-
suspension, the cells were standardized at an Optical Density (OD) of 600 n using a 
BioRad Smart Spec 3000 (BioRad, USA).  A result of 0.2 at OD600 is roughly equivalent 
109 CFU/mL of E. coli B as calculated from replicate dilution curves. All experiments 
were performed three times in > triplicate each.  
   E. coli B (ATCC 11303, Manassas, VA) were maintained in Tryptic Soy Broth 
medium for 12-16h at 37oC and examined in a direct contact model using the Free 
Suspension Assay [67] for 0-2h with or without TiO2 (1mg/mL) P-25 or Brookite-200, 
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separately. TiO2 nanoparticles were activated under long range ultra violet (UV) light 
(365nm; 364µW/cm2) at time points of 0, 30, 75, and 120 minutes in sterile water at pH 4 
or pH 7.4, or in Phosphate buffered saline (PBS) at pH 7.4.  Quantification of bacterial 
culture by Optical Density (OD) 600nm was verified prior to each experiment. 
Quantification of E. coli B was performed in triplicate by dilution plating with a Spiral 
Plater (Spiral Biotech, Norwood, MA) on Tryptic Soy Agar and incubated 24 h at 37oC 
and counted.  
To reduce the amount of material, time, labor, and cost, two different assay types 
were evaluated in order to miniaturize the assays. Dilution curves of E. coli B (n=8) were 
evaluated. The Live/Dead® BacLight™ Bacterial Viability Assay (L-7012, Molecular 
Probes, Eugene, OR) is a fluorescence based assay for distinguishing live and dead 
bacteria in a mixed population. SYTO® 9 green-fluorescent nucleic acid stain (480/500 
nm) penetrates healthy bacterial cells labeling all bacteria in a population; propidium 
iodide (490/635 nm) penetrates only bacteria with damaged membranes, causing a 
reduction in the SYTO 9 stain fluorescence when both dyes are present.  
A second assay was also evaluated. The Luminescent Assay Bac Titer-Glo™ 
Microbial Cell Viability Assay (Promega: Madison, WI, USA) quantitates the amount of 
ATP present in metabolically active cells. It is based on the luciferase reaction. Mono-
oxygenation of luciferin is catalyzed by luciferase in the presence of Mg2+, ATP, and 
molecular oxygen. 
Because Phosphate has a very high affinity to TiO2, acidic sterile water (AW) at 
~pH4 (2mL of 0.1M HCl / 100mL water) was used for these assays instead of Phosphate 
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Buffered Saline. Cells were washed three times in AW with centrifugation. Upon re-
suspension, the cells were standardized at an Optical Density (OD) of 600 n using a 
BioRad Smart Spec 3000 (BioRad, USA).  A result of 0.2 at OD600 is roughly equivalent 
109 CFU/mL of E. coli B as calculated from replicate dilution curves. 
 The six well – six mL volume free suspension assay was miniaturized to a 24 well 
format using a 1 mL volume assay. Many testing variables could evaluated at the same 
time under this new assay format. A non-fluorescing optically clear film (TemPlate® RT 
Optical Film, 2978-2700, USA Scientific, Inc.) was adhered to the polystyrene plate to 
prevent evaporation of the bacterial suspension in AW. The lamp intensity was adjusted 
to accommodate the film via the Radiometers. 
After testing, 100 µL aliquots (n=4) from each sample well was dispensed into a 
96 well black or white plate for fluorescence or luminescence assay, respectively. The 24 
well testing assay in combination with either the fluorescent LIVE/DEAD® BacLight™ 
Bacterial Viability Kit or the luminescent BacTiter-Glo™ Microbial Cell Viability Assay 
was evaluated after subtracting the background and to determine if the background was 
too large. Different Titania concentrations were evaluated, 0.1 mg/mL, 1 mg/mL or 10 
mg/mL in both assays.  
Miniaturized, modified free suspension assays were performed to determine a 
starting point for the amount of TiO2 to use in the coatings.  Because preliminary dilution 
curve results indicated linearity with minimal background in the 103 to 108 CFU/mL or 
102-107 CFU/mL range with the LIVE/DEAD® BacLight™ Bacterial Viability Kit or the 
luminescent BacTiter-Glo™ Microbial Cell Viability Assay, respectively, these assays 
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were used for higher bacterial loads in experiments, specifically the BacLight™ as it 
conserved time better than the cTiter-Glo™ with similar results. All modified free 
suspension assay Titania concentrations were 1 mg/mL. 
To determine the lower viable range (100-104 CFU/mL) of E. coli B, either Spiral 
Plating (Spiral Biotech Autoplate, Model 4000) or manual cell spreading on Tryptic Soy 
Agar petri dishes were performed in triplicate. The bacteria were incubated at 37oC for 
~24 h and enumerated. Results from these assays are normalized and plotted as Time (x- 
axis) versus % Survival (y- axis). Calculations were based on the number of  viable cell 
counts at various time points as percentages described in Equation 3.  All experiments 
were replicated for reproducibility. 
 _ Number of Viable Cells (CFU/mL) at Time t_____  X   100              (3) 
            Number of Viable Cells (CFU/mL) at Time t0 
 E. coli B cultures were incubated in TSB for 12-14 h in an Environmental 
Incubator Shaker (Model G24, New Brunswick Scientific). The cultures were harvested 
and centrifuged at 7,000 x g in a microcentrifuge (Eppendorf Centrifuge, Model 5417R) 
in AW. The coated cover slips (22 mm in diameter) (#72227-01, No2 Micro Coverglass; 
Electron Microscopy Sciences, Hatfield, PA) were aseptically inserted into 24 well 
plates. Because the 24 well plates used had a 22.2 mm diameter bottom, a secure ring was 
not needed to retain the bacteria on the coated cover slip.   
 Because Phosphate has a very high affinity to TiO2, acidic sterile water (AW) at 
~pH4 (2mL of 0.1M HCl / 100mL water) was used for these assays instead of Phosphate 
Buffered Saline. Cells were washed three times in AW with centrifugation. Upon re-
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suspension, the cells were standardized at an Optical Density (OD) of 600 n using a 
BioRad Smart Spec 3000 (BioRad, USA).  A result of 0.2 at OD600 is roughly equivalent 
109 CFU/mL of E. coli B as calculated from replicate dilution curves. 
E. coli B cells at 1 x 104 CFU/mL AW were aliquoted 1 mL per well into a 24 
well plate containing various coated cover slips. Exposure times of 0, 2, 4, 6, 8, 10, 20, 
30, 40, 50, or 60 minutes were evaluated. At the end of each time period, the samples of 
E. coli B (50 µL), using either Spiral Plating (Spiral Biotech Autoplate, Model 4000) or 
manual cell spreading on Tryptic Soy Agar petri dishes were performed in triplicate. The 
bacteria were incubated at 37oC for ~24 h and enumerated. Results from these assays are 
normalized and plotted as Time (x- axis) versus log 10 Survival (y- axis). Calculations 
were based on the number of viable cell counts at various time points as percentages 
described in Equation 3.   
The B or P sub-coatings with or without Br200, Br-NMP, P25, or VLP7000 
Titania were evaluated for photocatalytic activity. Sub-coatings alone without Titania 
were used for the controls. A multiple ray lamp (MRL, Model 58; Fisher Scientific) with 
different 8 Watt tubes UVA (365nm) at 363-364 µW/cm2) and visible light (Cool White) 
at 0.100 mW/cm2) was utilized as the source for photoactivation.  The intensity of light 
was verified with a UVX Digital Radiometer, (Model-UVX, UVP, Inc., Upland, CA) and 
an ACCU- CAL-50-V (Dymax Corporation, CT) for UVA and visible light, respectively. 
Polystyrene plates (24-well) containing the Titania coated cover slips were secured onto a 
microplate orbital mixer (Microplate Genie, Model SI-0400, VWR).  One milliliter of 1 x 
104 E. coli B in AW was added to each well. A non-fluorescing optically clear film 
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(TemPlate® RT Optical Film, 2978-2700, USA Scientific, Inc.) was adhered to the 
polystyrene plate to prevent evaporation of the bacterial suspension in AW. The lamp 
intensity was adjusted to accommodate the film via the Radiometers. 
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Figures 3.8.1. A-E - Surface chemical spectra of sub-coating with and without 
Titania 
 























































B) PDDA/PSS with P25 
C) PDDA/PSS with VLP7000 
D) PDDA/PSS with Br200 
E) PDDA/PSS with BrNMP 
F) Binder 
G) Binder with P25 
H) Binder with VLP7000 
I) Binder with Br200 






Figure 3.8.5. Photocatalytic Activities of Titania Coatings Under UVA 
 
Statistics were determined using a student T-Test with alpha equal to 0.05. P or B Sub-Coating with MO 
(20 µM) in water at pH 4.0 exposed to UV light (365nm) with a (363-364 µW/cm2) intensity in with or 
without P- P-25 26+ h and P-Br200 14 h, or P-BrNMP 10 h, B- P-25 28+ h and B-Br200 22 h, or B-
BrNMP 18 h oxidative degradation of MO. Br200 and BrNMP were significantly different from 2 h -26 h 
(p= 0.02 – 0.005); P25 was significantly different from16 h-28 h (0.044 – 0.032).  MO alone or on P or B- 
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Figure 3.8.6. Photocatalytic Activities of Titania Coatings Under Visible Light 
 
Statistics were determined using a student T-Test with alpha equal to 0.05. P or B Sub-Coating with MO 
(20 µM) in water at pH 4.0 exposed to VL  with a (100 µW/cm2) intensity in with or without P- P-25 26+ h 
and P-Br200 14 h, or P-BrNMP 14h, B- P-25 28+ h and B-Br200 16 h, or  B-BrNMP 20 h oxidative 
degradation of MO. Br200 and BrNMP were significantly different from 2 h -26 h (p= 0.03 – 0.004); P25 
was significantly different from 8 h-28 h (0.03 – 0.01).  MO alone or on P or B- Sub-Coating was not 
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Figure 3.8.7.  Activated TiO2 exposed to Escherichia coli B at pH 7.4 in water or PBS 
for 120 Minutes  
 
Results were determined using a student T-Test with alpha equal to 0.05. E. coli B in PBS pH 7.4 or water 
at pH 7.4 exposed to UV light (365nm) in the absence or presence of TiO2 P25 or TiO2 Brookite 
maintained the original bacterial population in 120 minutes. The pH of the water at 120 minutes dropped 
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Figure 3.8.8.  TiO2 Degradation of Escherichia coli B with or without UV at 0, 30, 75, or 
120 Minutes in Water at pH 4.0 
 
Results were determined using a student T-Test with alpha equal to 0.05. E. coli B in water at pH 4.0 
exposed to UV light (365nm) in the presence of TiO2 P-25 and TiO2 Brookite had a significant seven log 
drop in 120 (p=0.004) or 30 (p=0.001) minutes, respectively. E. coli B in the absence of TiO2 in water at 
pH 4.0 depicted no significant reduction of the bacterial population in 120 minutes. The water beginning at 
pH 4.0 remained the same throughout 120 minutes. (Error bars may be too small to be seen.) 
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Where:   = Interfacial tension between the solid and gas    
 
     = Interfacial tension between the solid and liquid     
 



















Figure 3.8.10. BacLight Fluorescent Assay Linearity Range on Escherichia coli B with p 
values less than 0.05 
  
















Figure 3.8.11.  Bac-Titer-Glo™ Luminescent Assay Linearity Range on Escherichia coli 
B with p values less than 0.05 
 



















Figure 3.8.12. Effects of UVA Activated P25, Br200 and BrNMP Titania 1 mg/mL in 
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Figure 3.8.13.  Effects of UVA Activated P25 and Br200 Titania 1 mg/mL in Free 
Suspension on E. coli B  
 
Percent survival of E. coli B (EC) CFU/mL with and without P25 or  Br200 Titania exposed to a UVA at 
365 nm for either 0, 30, 60, 90, or 120 seconds or the dark for 0, 90, or 120 seconds. Student T-Test 
indicated significant difference at an alpha of 0.05 between EC at 0 sec to P25, not significantly different at 
0, or 90-120 sec in the dark, but significantly different at 30 – 120 sec in UVA (p= 0.004 – 0.002); between 
EC at 0 min sec to  Br200, not significantly different at 0 min UVA or 90 - 120 sec D or at 30 sec in UVA; 
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Figure 3.8.14. Effects of Visible Light Activated VLP7000, Br200 and BrNMP Titania 
1mg/mL in Free Suspension on E. coli B  
 
Percent survival of E. coli B (EC) CFU/mL with and without VLP 7000, Br200, and BrNMP Titania 
exposed to a cool white 8 Watt bulb for either 0, 10, 20, 30, 40, 50, or 60 minutes or the dark for 0, 30, or 
60 minutes. Student T-Test indicated significant difference at an alpha of 0.05 between EC at 0 min to P25, 
not significantly different at 0 or 10 min VL; significantly different at 20 – 60 min VL (p= 0.01 – 2.5 x 10-
5), and at 30 – 60 min D (p= 0.039 – 0.002); between EC at 0 min to  Br200, not significantly different at 0 
min VL or 30 – 60 min D (p= 0.3 – 0.2), but significantly different at 10 – 60 min VL (p= 0.001 – 1.9 x 0-
8); and between EC at 0 min to BrNMP, not significantly different at 0 min VL, but significantly different 
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Figure 3.8.15. Effects of UVA Light Activated P-25, Br200 and BrNMP Titania (2mg) 
on the PDDA/PSS Sub-coating on E. coli B for 0-60 Minutes 
 
Percent survival of E. coli B (EC) CFU/mL with and without P25, Br200, and BrNMP Titania  on P Sub-
Coating exposed to a UVA 365 nm lamp for either 0, 10, 20, 30, 40, 50, or 60 minutes or the dark for 0, 30, 
or 60 minutes. (Error bars may be too small to see.) Student T-Test indicated significant difference at an 
alpha of 0.05 between EC at 0 min to P25, not significantly different at 0 or 10 min UVA; significantly 
different at 20 – 60 min VL (p= 2.5 x 10-5 – 1.3 x 10-6), and at 30 – 60 min D (p= 0.039 – 0.002); between 
EC at 0 min to  Br200, not significantly different at 0  or 10 min UVA or 30 – 60 min D (p= 0.3 – 0.2), but 
significantly different at 20 – 60 min UVA (p= 5 x 10-4 – 1. X 10-6); and between EC at 0 min to BrNMP, 
not significantly different at 0 or 10 min UVA, or 30 – 60 min D, but significantly different at 20 – 60 min 
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Figure 3.8.16. Effects of UVA Light Activated P-25, Br200 and BrNMP Titania (2mg) 
on the Binder Sub-coating on E. coli B for 0-60 Minutes 
 
Percent survival of E. coli B (EC) CFU/mL with and without P25, Br200, and BrNMP Titania on B Sub-
Coating exposed to a UVA 365 nm lamp for either 0, 10, 20, 30, 40, 50, or 60 minutes or the dark for 0, 30, 
or 60 minutes. (Error bars may be too small to see.) Student T-Test indicated significant difference at an 
alpha of 0.05 between EC at 0 min to P25, not significantly different at 0 min UVA; significantly different 
at 10 – 60 min UVA (p= 0.01 – 0.001), and at 30 – 60 min D (p= 0.04– 0.002); between EC at 0 min to  
Br200, not significantly different at 0 min UVA  or 30 – 60 min D (p= 0.3 – 0.2), but significantly different 
at 10 – 60 min UVA (p= 0.001 – 0.01); and between EC at 0 min to BrNMP, not significantly different at 0 
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Figure 3.8.17. Effects of Visible Light Activated VLP7000, Br200 and BrNMP Titania 
(2mg) with PDDA/PSS Sub-coating on E. coli B for 0-60 Minutes  
 
Percent survival of E. coli B (EC) CFU/mL with and without VLP 7000, Br200, and BrNMP Titania on P 
Sub-Coating exposed to a cool white 8 Watt bulb for either 0, 10, 20, 30, 40, 50, or 60 minutes or the dark 
for 0, 30, or 60 minutes. (Error bars may be too small to see.) Student T-Test indicated significant 
difference at an alpha of 0.05 between EC at 0 min to P25, not significantly different at 0 min VL or 30 – 
60 min D; significantly different at 10 – 60 min VL (p= 0.01 – 0.003); between EC at 0 min to  Br200, not 
significantly different at 0, 2, 4, or 6 min VL or 30 – 60 min D (p= 0.3 – 0.2), but significantly different at 8 
– 60 min VL (p= 0.002 – 4 x 0-11); and between EC at 0 min to BrNMP, not significantly different at 0 min 
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Figure 3.8.18. Effects of Visible Light Activated VLP7000, Br200 and BrNMP Titania 
(2mg) with Binder Sub-coating on E. coli B for 0-60 Minutes 
 
Percent survival of E. coli B (EC) CFU/mL with and without VLP 7000, Br200, and BrNMP Titania on B 
Sub-Coating exposed to a cool white 8 Watt bulb for either 0, 1, 2, 4, 6, 8, 10, 20, 30, 40, 50, or 60 minutes 
or the dark for 0, 30, or 60 minutes. (Error bars may be too small to see.) 
Student T-Test indicated significant difference at an alpha of 0.05 between EC at 0 min to vlp7000, not 
significantly different at 0  or 10 min VL or 30 – 60 min D; significantly different at 20 – 60 min VL (p= 
0.005 – 0.001); between EC at 0 min to  Br200, not significantly different at 0, 2, 4, or 6, min VL or 30 – 
60 min D (p= 0.3 – 0.2), but significantly different at 8 – 60 min VL (p= 0.01 – 0.0002); and between EC at 
0 min to BrNMP, not significantly different at 0 min VL or 30 – 60 min D, but significantly different at 10 
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3.9 Tables 







X-ray Photoelectron Spectroscopy of Titania in Powder Form 
P25 Brookite-200 
Peak [Mass] % Peak [Mass] % 
O 1s 39.73 O 1s 38.97 
Ti 2p 48.22 Ti 2p 50.39 
C 1s 12.06 C 1s 8.33 
---- ---- Cl 2p 2.31 
 105 
Table 3.9.2. Surface chemical [Mass] % analysis of P or B Sub-coatings with or without 
Titania  
 
X-ray Photoelectron Spectroscopy of Titania Coatings 
PEAK PSS PSS+Br200 PSS+P-25 PSS+ BrNMP PSS+vlp7000 PSS+ Anatase 
Na 1s 7.94 8.68 12.93 6.56 5.88 5.88 
O 1s 24.63 32.79 28.96 21.87 32.3 34.68 
Ti 2p 0 6.81 10.5 0 5.2 9.77 
N 1s 3.32 3.73 2.46 5.58 3.68 2.26 
C 1s 57.24 32.12 33.01 61.6 34.21 26.67 
S 2p 6.88 4.3 5.12 4.39 5.61 3.92 








Table 3.9.3. Hydrophilicity measured by contact angle on P or B Sub-coatings with or 





P Sub-Coating with or without all types of Titania are significantly different at an alpha of 0.05 from all B 
Sub-Coatings with or without all types of Titania with a range of p values from 2.36 x 10-5 to 6.93 x 10-6.  
All B Sub-Coatings with or without all Types of Titania compared to all B Sub-coatings with or without all 







P Sub-Coating B Sub-Coating 
Alone < 1o Alone 62.5o 
P25 < 1o P25 51.5o 
Br200 < 1o Br200 52.5o 
vlp7000 < 1o vlp7000 105.0o 
BrNMP < 1o BrNMP 67.5o 
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CHAPTER FOUR 
EFFECTS OF PHOTOCATALYTICALLY ACTIVATED POLYMORPHIC 
BROOKITE TITANIA NANOPARTICLE WITH ENHANCED VIA NOVEL  
SUB-COATTINGS ON CANCER CELL VIABILITY in vitro 
 
(As a manuscript formatted for submission to the Journal of Nanobiotechnology) 
 
4.1 Abstract 
The most common form of cancer in the U.S. is skin cancer. The most dangerous 
type of skin cancer is melanoma. Exposure to sunlight or ultraviolet (UV) light causes 
about 65%-90% of melanoma incidence in the states. Current skin cancer treatments may 
involve surgery, radiation therapy, photodynamic therapy, hyperthermia therapy, and 
topical or systemic chemotherapy. For minimal skin cancers, a patient friendly product is 
needed. Titanium dioxide, a versatile non-selective compound with photocatalytic 
properties, degrades compounds through photo-oxidation and exists in three lattice 
phases, Anatase, Brookite, and Rutile. This study evaluated liquid band-aid with liquid 
phase deposition of polymorphic Brookite phase Titania. Br200 a Water-based Ambient 
Condition Sol (WACS) was coated onto liquid band-aid and assessed for cytotoxicity on 
cancer cells in vitro.   
Long range ultraviolet light (UVA) photocatalytically activated P25 or Br200 
Titania with or without liquid band-aid was evaluated for cytotoxicity on HT-29 Human 
Colon Cancer Cells or HTB-67 Human Malignant Melanoma Cells in vitro. Both cell 
types resulted in a similar trend. Br200 under UVA without liquid band-aid eliminated 
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both cell types within 30 minutes. Br200 under UVA with liquid band-aid or P25 under 
UVA with and without liquid band-aid eliminated all cells within 60 minutes. P25 in the 
dark with and without liquid band-aid killed approximately 0.5 log of cells. Cells under 
UVA alone or with liquid band-aid remained at the initial concentration. Except for 
variables containing P25, all dark exposed cells remained viable at the initial 
concentration.  
Light intensity, wavelength, surface material characteristics, pH, types of ionic 
molecules in surrounding areas, and target load affect efficiency of photo-oxidation. The 
Br200 5-8nm diameter crystallite size range provides a greater surface area, significantly 
increasing target contact probability. Br200 Titania indicated superior photo-oxidative 
activity when exposed to UVA than the commercial P25 on both HT-29 and HTB-67 
cells. This novel format of using FDA approved liquid band-aid coated on one side with 
Br200 non-selective Titania coating may provide lower pain and scarring for removal of 
cancer cells.  
 
4.2 Introduction  
In the U.S., skin cancer is most prevalent with melanoma the most dangerous type 
and the third most common. Exposure to ultraviolet (UV) light or sunlight causes about 
65%-90% of the melanomas [47]. In the U.S., 2006, melanomas of the skin were 
diagnosed in 53,919 people and 8,441 people died [48]. Current skin cancer treatments 
may involve surgery, radiation therapy, external beam radiation,  photodynamic therapy, 
topical, systemic, or fractionated dose chemotherapy, biotherapy, immunotherapy, and 
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local hyperthermia [49]. These treatments can cause devastation systemically throughout 
the body along with hair loss and other undesirable effects. 
Titania or Titanium dioxide (TiO2), is a versatile non-selective compound with 
photocatalytic properties, degrades compounds through photo-oxidation. Titanium 
dioxide exists in three different polymorphic lattice phases, Anatase, Brookite, and 
Rutile. Rutile phase is the most thermodynamically stable due to its minimal electrostatic 
repulsive energy; it is abridged in a linear structure with two of the twelve edges of the 
octahedron are shared [8]. Anatase phase shares four edges per octahedron without corner 
oxygen sharing.  Uniquely, Brookite phase is composed orthorhombically with three 
shared edges per octahedron.  
Zallen and Moret measured the optical absorption edge of Brookite Titania [9]. 
Extending throughout the visible light range, Brookite was observed to have a broad 
absorption edge in contrast to the steep absorption edges of Anatase and Rutile. In the 
evaluated spectral range, no evidence of a direct gap was observed. They suggest that 
Brookite phase Titania may function as an indirect-gap semiconductor with an 
approximate bandgap of 1.9 eV [9]. In contrast, calculations using the self-consistent 
orthogonalized linear-combination-of-atomic-orbitals method, Mo and Ching, 1995 
approximated a direct bandgap for Brookite [10]. Other researchers have determined that 
all three phases of Titania have similar direct bandgap energies (~3.1 + 0.1 eV) [11]. 
Banerjee and colleagues report the bandgap values for each phase is Anatase (3.2 eV), 
Rutile (3.02 eV), and Brookite (2.96 eV) [12]. Whether direct or indirect, polymorphic 
Brookite phase Titania exhibits the lowest bandgap energy. 
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Researchers have used Atomic Force Microscope (AFM) to visualize the 
antimicrobial photocatalytic activity of photo-activated Titania [12]. This same 
phenomenon is expected to work on mammalian cells. The characteristics of a 
photocatalyst include its ability to simultaneously adsorb two reactants. Then efficiently 
adsorb light (hv > Eg) to reduce and oxidize the adsorbed reactants. The absorbed light 
energy must be larger than the bandgap to excite the e- from the valence band to the 
conduction band producing an e--h+ pair. In the presence of water and dissolved oxygen 
(H2O/O2), the positive holes oxidize water splitting it into .OH and H+. The dissolved 
oxygen is reduced by the photo electron of the conduction band, generating superoxide 
anions (.O2-). H+ combines with the (.O2-) generating a hydroperoxyl radical, eventually 
producing a reactive oxygen species (ROS) H2O2 molecule. The photo induced ROS 
hydroxyl radical and hydrogen peroxide cause biocidal catalysis by penetrating cell walls 
and cutting DNA strands. The super oxide anion can enter the cell after oxidizing holes 
are made. Once inside, hydrogen peroxide and the super oxide anion may become 
hydroxyl radical precursors. Once inside the cell wall (Fe2+) may activate hydrogen 
peroxide by the Fenton reaction, causing cell death via cell wall destruction and strong 
DNA damage. 
Phosphate ions from Phosphate Buffered Saline have a very high affinity for the 
Titania. Phosphate ions bind to the substrate surface causing the isoelectric point of the 
TiO2/aqueous interface to significantly shift downward to pH 2.0 and increasing the 
3400cm-1peak intensity measured by vibrational sum-frequency spectroscopy (VSFS).  
[62]. The isoelectric point was ~5.5 in the presence of Cl- ions. 
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This work investigated one type of polymorphic Brookite phase Titania, Br200, 
and the commercial Titania P-25 from Degussa, Germany consisting of Anatase phase 
79% to the Rutile phase of 21% on liquid band-aid (LB). The samples will be evaluated 
for their photocatalytic ability with exposure to UVA 365 nm on Human Colon Cancer 
cells HT-29 and Human Malignant Melanoma Cells HTB-67. The Titania-LB will be 
examined via Fourier Transform-Infrared Spectrometry. 
4.3 Results  
Fourier Transform-Infrared Spectrometry verified that Titanium molecules were 
present in the LB coatings (Figure 1).  XPS spectral graphs of the LB sub-coating with 
and without P25 or Br200 are depicted in Figures 4.8.1 and 4.8.2, respectively. 
Long range ultraviolet light (UVA at 365nm) photocatalytically activated P25 or 
Br200 Titania with or without liquid band-aid were evaluated for cytotoxicity on HT-29 
Human Colon Cancer Cells or HTB-67 Human Malignant Melanoma Cells in vitro. 
Figure 4.8.3 depicts representative photos of the cells. Figures 4.8.4 (p = 0.01 to 0.00003) 
and 4.8.5 (p = 0.02 to 0.00003) depict the quantitative graphs of Viable Cells at different 
time points of treatments. Both cell types resulted in a similar trend. Br200 under UVA 
without LB eliminated both cell types within 30 minutes. Br200 under UVA with liquid 
band-aid or P25 under UVA with and without LB eliminated all cells within 60 minutes. 
P25 in the dark with and without LB killed approximately 0.5 log of cells. Cells under 
UVA alone or with LB remained at the initial concentration. Except for variables 
containing P25, all dark exposed cells remained viable at the initial concentration.  
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4.4 Discussion  
Fourier Transform-Infrared Spectrometry verified that Titanium molecules were 
present in the LB coatings, allowing the Titania to have direct contact with the organic 
substance to be degraded. Low temperature calcination of 200oC for 2 h on both Br200 
Titania produced crystallite sizes ranging from 5-8 nm, therefore, providing a very high 
surface area ranging from (BET) 138 - 157 m2/g [65]. This provides a significantly 
greater surface area per particle than the Degussa commercial P25 reference standard at 
(BET) 56 m2/g with 79% Anatase and 21% Rutile phase TiO2. FT-IR Spectral graphs are 
shown in Figure 4.8.1 comparing P25 to Figure 4.8.2 Br200 Titania with and without LB. 
4.5 Conclusions  
According to the results obtained in this study, Br200 Titania with and without 
LB provided superior oxidative activity on both HT-29 and HTB-67 cancer cell 
decomposition compared to the commercial P25 TiO2 from Degussa, (Evonik Industries 
AG, Germany).  One explanation is reported by Zallen and Moret, 2006. At ambient 
temperature, natural Brookite TiO2 crystals were examined via optical-absorption ranging 
from 2.1 to 3.54 eV.  The Brookite TiO2  absorption edge is broad, continuing throughout 
the visible range with no direct gap [9].  In contrast to tetragonal forms, the orthorhombic 
structure encompasses a larger range of bond lengths from the six unique nearest-
neighbor Ti-O bond lengths. They suggest that Brookite TiO2 has indirect-band-gap 
semiconductor properties with a bandgap approximating 1.9 eV. The narrowing off the 
band gap will shift the absorption edge into the visible range. 
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 Due to the low temperature method in which the Br200 was formed and calcined, 
provided small crystallite sizes ranging from 5 – 8 nm in diameter, producing a large 
surface area, approximately (BET) 157 m2/g [66].  This large surface area would provide 
more opportunities for contact with molecules or cells.  The smaller crystallite size allows 
for more particles to make up a specific mass, hence providing extremely large surface 
area for photocatalytic activity.  
 Therefore, LB coatings with Br200 Titania may provide a non-selective method 
of killing cancer cells that causes less pain and less scarring, and deliver a patient friendly 
and effective cancer treatment. 
4.6 Experimental 
Titanium dioxide Br200 nanoparticles samples were graciously given to our lab 
by Dr. B. I. Lee and Dr. S. Kaewgun at Clemson University. The donated Br200 
nanoparticles were made by the WACS process as described in [66]. This sample was 
calcined at 200oCelsius for 2 hours (h) in air. The commercial TiO2, P25 from Degussa, 
(Evonik Industries AG, Germany) was used for long wave ultraviolet light (UVA) 
(365nm) comparisons of activity to Br200.  
FTIR analysis was performed using a Thermo-Nicolet Magna 550 FTIR 
spectrometer equipped with a Thermo-Nicolet Nic-Plan FTIR Microscope. Thin films of 
the gels (New Skin Liquid Band-Aid; Prestige Brands, Inc., USA) with and without 
Br200 or P25 were cast onto IRTran Plates and dried under an IR heat lamp. Scans (64) 
at a resolution of 4cm-1 were collected for the sample and also for the background (clean 
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IRTran Plate) in transmission mode on the microscope. Samples were analyzed over the 
range of 4000cm-1 to 700cm-1. Data was analyzed using Omnic Data Analysis software 
and absorbance peaks labeled with wavelength (cm-1).  
Each Titania, Br200 or P25, or was mixed into sterile Hanks Balance Salt 
Solution (HBSS) sonicated for 1 h and vortexed for 1 minute. A thin coat of LB was 
painted onto wax paper matching the size of the well bottom of the 24-well plate.  After 
drying, 150 µL of the appropriate Titania-HBSS was deposited and air dried for use. 
 The cell culture assays were conducted using HTB-67 Human Malignant 
Melanoma Cells and HT-29 Human Colon Cancer Cells (HTB-38; ATCC, Manassas, 
VA). The cells were shipped cryopreserved at the end of their tertiary culture in the 
appropriate culture medium and 5% dimethylsulfoxide (DMSO) (Sigma, St. Louis, MO).  
Based on ATCC's product information sheet, HTB-67 cells were spherical and grew in 
suspension using 15 mL of medium Eagle’s Minimum Essential Medium (EMEM) and 
10% Fetal Bovine Serum (FBS). HT-29 cells are epithelial and adherent growing in 
ATCC-formulated McCoy's 5a Medium Modified, Catalogue No. 30-2007, plus 1% 
antibiotic solution with FBS to a final concentration of 10%. They were subcultivated in 
T-75 culture flasks (Corning canted neck flasks with vented caps, (VWR, Atlanta, GA) in 
a 37°C, 5% CO2, 95% air, humidified culture incubator with Work was carried out in a 
class 2 A/B3 biological safety cabinet.  Hanks' Balanced Salt Solution (HBSS) plus 1% 
antibiotic solution, modified without calcium chloride, magnesium chloride, or phenol 
red (ATCC 30-2213) was used for washing cells and the test experiments.  For tests, 1 X 
105 cells/38cm2 were inoculated and grown to 90% confluency in 24-well tissue culture 
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treated plates (VWR, Atlanta, GA). Cells were rinsed in HBSS twice prior to testing and 
HBSS was the testing diluent.  HBSS had the least affect on the Titania.  
 LIVE/DEAD® Viability/Cytotoxicity Kit— (Molecular Probes; Eugene, OR) 
Calcein AM   EX/EM 494/517 is membrane-permeant, cleaved by esterases in live cells 
resulting in cytoplasmic green fluorescence. Ethidium homodimer-1 EX/EM 517/617 is 
membrane-impermeant and labels nucleic acids of membrane-compromised cells with 
red fluorescence. The cells were exposed to either UVA 365nm at 363-364 µW/cm2 or 
dark for different time periods with and without Br200 or P25 Titania, using 1mg/mL 
free suspension or 2mg/38mm2 coatings. Following the Live/Dead product sheet, the 
cells were incubated for 1 h then observed and photographed under a fluorescent 
microscope.  There were 4 wells per variable with 4 random pictures taken per well.  
Cells were observed for morphology and life.  
The Titania were weighed and mixed into HBSS at either 1mg/ml in free 
suspension or 14mg Titania/mL HBSS for the coatings. The liquid Titania suspensions 
were sonicated (Sonicator FS30H; Fisher Scientific) for 1 h and vortexed.  Each well 
received 1mg/mL of either Br200 or P25 Titania. Each treated liquid Band-aid (LB) slip 
received one aliquot of 150 µL of Br200 or P25 suspension, (2mg/38mm2) and was air 
dried at ambient temperature between aliquots, then stored aseptically at room 
temperature for further use.  
Phosphate Buffered Saline (PBS) was not used as the diluent because Phosphate 
ions from Phosphate Buffered Saline have a very high affinity for the Titania. Phosphate 
ions bind to the substrate surface causing the isoelectric point of the TiO2/aqueous 
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interface to significantly shift downward to pH 2.0 and increasing the 3400cm-1peak 
intensity measured by vibrational sum-frequency spectroscopy (VSFS) [62]. 
The LB coating with or without Br200 or P25 Titania was evaluated for 
photocatalytic activity. Cells alone without treatment were the negative control and cells 
with free suspension Titania were used for the positive controls. A multiple ray lamp 
(MRL, Model 58; Fisher Scientific) with different 8 Watt tubes UVA (365nm) at 363-364 
µW/cm2) and visible light (Cool White) at 100 µW/cm2) was utilized as the source for 
photoactivation.  The intensity of light was verified with a UVX Digital Radiometer, 
(Model-UVX, UVP, Inc., Upland, CA) for UVA light. Polystyrene plates (24-well) 
containing the cells were secured onto a microplate orbital mixer (Microplate Genie, 
Model SI-0400, VWR).  One milliliter of 1mg/mL Br200 or P25 HBSS solution was 
added to each well in free suspension. Each coating was placed into well containing 
1X105 cells in HBSS.  A non-fluorescing optically clear film (TemPlate® RT Optical 
Film, 2978-2700, USA Scientific, Inc.) was adhered to the polystyrene plate to prevent 
evaporation of the MO. The lamp intensity was adjusted to accommodate the film and the 
liquid band-aid.  
Plates were at 0, 5, 10, 15, 30, and 60 minutes, the experiment was run backward 
so the times would come due at the same time for each plate. The cells were washed 
twice in HBSS to remove the free Titania. The wells containing had the coatings removed 
and cells rinsed twice. The Live/Dead Assay was applied and read after 1 h incubation 
using a fluorescent microscope. Four random images were taken of each sample and the 
cells were counted. Calculations were based on the change in viable cells counts at 
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various time points as percentages described in Equation 1.  All experiments were 
replicated for reproducibility. 
 _Change in Number of Viable Cells_       X   100%                   (1) 
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Figure 4.8.3. Representative Photos of Live/Dead Cytocompatibility HTB-67 Human Malignant 






Figure 4.8.4. Representative Photos of Live/Dead Cytocompatibility HTB-67 Human Malignant 









Figure 4.8.5. Effects of UVA photoactivation on HTB-67 Melanoma cells by Br200 or 
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Figure 4.8.6. Effects of UVA photoactivation on HT-29 Colon Cancer cells by Br200 or 





















C UV C D C UV P25 NS C D P25 NS
C UV Br200 NS C D Br200 NS C UV NS C D NS






As MDR bacteria and biofilms become more prevalent and resistant in both the 
nosocomial and community settings, non-selective surface coatings that eradicate these 
super bugs are truly needed. In our first study, we created a super-hydrophilic-
polyelectrolyte-Brookite phase Titania coating. We obtained positive results in 
characterizing the coatings through surface chemical analysis and XRD. We verified that 
the polyelectrolyte super-hydrophilic-Brookite phase Titania coating contained the 
Titania particles on the surface and that the spectra peaks corresponded to the lattice 
structure in the original Brookite phase nanoparticle powered Titania provided to our lab 
by Dr. Lee. The polyelectrolyte coatings containing Br200 Titania were superior to 
BrNMP, the commercial P25 from Degussa, and the commercial Kronos VLP7000 in 
every evaluation in both UVA and VL light against different loads of bacteria.  To our 
knowledge, this is the first super-hydrophilic-polyelectrolyte-Brookite phase Br200 
Titania coating. This novel polyelectrolyte-Br200 non-selective Titania coating can 
provide a low cost, effective non-selective method of preventing transmission of bacterial 
infections, or prevention of biofilm formation in the nosocomial and community settings. 
The Brookite phase Titania was also evaluated on cancer cells, HT-29 human 
colon cancer cells and HTB-67 human malignant melanoma cells in vitro.  Again, the 
Br200 Titania whether in free suspension or used as a coating with liquid band-aid, it 
proved significantly superior to the commercial Anatase phase, P25 from Degussa. To 
our knowledge, this is the first study to evaluate this novel format of using FDA approved 
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liquid band-aid coated on one side with Br200 non-selective Titania coating and can 
provide lower pain and scarring for removal of skin cancers in a patient friendly format. 
The objectives of this research were obtained. First the free suspension assay was 
modified and miniaturized with three different methods. For high bacterial loads, the 
BacLight Live Dead Assay and the BacTiterGlo Assay provide a fast and multiple 
variable 96-well format for quantitative measurements using fluorescence or 
luminescence plate reader and qualitatively using fluorescence microscopy. With a lower 
bacterial load, spread plating from a 24-well plate format provides superior low number 
counts. The modified and miniaturized assay was adapted for use with coatings.  Twenty-
two millimeter glass cover slips were used as the coating base and fit in the 22.2 mm 
diameter wells of the 24-well plates. Twenty-four samples could be evaluated at one time 
with spread plating techniques for quantification. 
The novel P sub-coating was developed and characterized via XRD to confirm a 
match with the original properties of the loose nanoparticles. XPS further characterized 
the molecules present on the surface of the coatings, indicating that Ti, O, N, and S were 
on the surfaces. Complete death curves were quantified for each type of Titania, P25, 
Br200, BrNMP, and vlp7000 both in free suspension and comparing the new P sub-
coating with and without Titania to the B sub-coating with and without Titania. The death 
curves were performed under UVA or VIS light for the appropriate types of Titania. 
Br200 remained superior to all other types of Titania evaluated in the coatings under both 
UVA and VIS light. In fact, Br200 with the P sub-coating killed all bacteria within 8 
minutes under VIS light. In previous work by our lab’s researchers their coating with 
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Br200 required over 8 hours of exposure to kill 3 logs of cells difference from the Br200 
cells in the dark.  
 Methyl Orange oxidative-degradation using the P sub-coating with Br200, 
BrNMP and UVA (P25) or VIS light (vlp7000) with an 8 Watt lamp yielded total 
degradation.  Total degradation occurred under UVA and P sub-coatings with Br200 and 
BrNMP in 10-12 hours and under VIS light and P sub-coatings with Br200 and BrNMP 
in 14 hours. These results indicate the uniqueness of the P sub-coating bound with the 
Br200 and BrNMP Titania. 
 Because of these results of the P sub-coating with the polymorphic Brookite 
Br200 and BrNMP, low temperature surface interactions between the P sub-coating N 
and/ or S molecules and the Titania may occur. These molecules are enhancing the 
photocatalytic activity of the polymorphic Brookite Br200 and BrNMP by increasing the 
absorption edge and narrowing the ban-gap. To our knowledge, this is the first time that 
low temperature interactions via the P sub-coating, positively affecting Titania 
photocatalytic properties in this manner has been described. Therefore, this work 
contributes to the scientific body of knowledge. The P sub-coating is novel and has 
enhancing abilities to increase the photocatalytic activity of polymorphic Brookite, 
Br200, and BrNMP.  
Due to the superior results of Br200, it was chosen for the in vitro cancer work as 
a feasibility proof of concept model. Br200 and P25 were examined with the LB sub-
coating to kill cancer cells under UVA irradiation. Again, Br200 with the FDA approved 
LB sub-coating was found superior. This work may contribute to the enrichment of 
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cancer patients’ lives, by receiving treatment that is less deleterious throughout the body, 
causes less scarring and pain. Finding a new treatment for cancer also contributes to the 























The super-hydrophilic-Brookite phase Br200 Titania coating should be 
characterized further by evaluating to verify the coated Titania retains the same 
characteristics as the original nanoparticle powder. Characterize and verify in detail how 
the P sub-coating containing the N and S molecules enhance the polymorphic Brookite 
Br200 and BrNMP Titania. 
1. Solid state 1H MAS NMR measurements, used to distinguish and analyze the 
amount of surface hydroxyls and lattice hydroxyls as minimization increases 
photocatalytic activity 
2. N2 physisorption to verify BET surface area, pore volume, average pore diameter, 
and pore size distribution of TiO2 on coatings 
3. Fourier-Transform Infrared Spectroscopy (FT-IR) to verify vibrational bands for 
total water and -OH groups on coatings 
4. ATR for the semiquatitative analysis of hydroxyls on coatings 
5. Diffuse Reflectance Infrared Fourier Transform (DRIFT) spectroscopy to confirm 
that the ATR is valid for the semiquatitative analysis of hydroxyls  
 Because, light intensity, wavelength, surface material characteristics, and bacterial 
load affect efficiency of photo-oxidation, further evaluation of the novel P sub-coating is 
warranted. 
6. Different loads of and species of bacteria should be evaluated under both UVA 
and VL light on the novel sub-coatings with Titania 
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7. Test comparing VL light on the novel sub-coatings with Titania 
8. Different strains of human melanomas on the LB novel sub-coatings with Titania 
9. Observe the effects in an in vivo murine model. The immunohistochemistry 
marker HMB-45 will stain malignant melanoma.  
10. Test more variables and reproducibility in the in vivo work for statically 
significant results 
11. Further characterization of the liquid band-aid-Br200 coating to verify the Br200 
Titania as listed above with the first coating.  
12. File for IP 
13. Look into Clinical Trials 
















A.1. Visible Wavelength Spectra: Emission range of Cool White 8 Watt Lamp for VL 












Figure A.2. Spectra emission wavelength range of 365nm with filter 8 Watt Lamp for 



















B. XPS Spectral Graphs  
 



















                       
 




                              
 





     

























































































































XPS high resolution spectral graph of Silicon 2p in Br200 TiO2 with PSS/PDDA Sub-
Coating 
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XPS spectral graph of BrNMP TiO2 with PSS/PDDA Sub-Coating 
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XRD spectral graph of PSS/PDDA alone on glass cover slip 
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 XRD spectral graph of PSS/PDDA with P25 TiO2 on glass cover slip 
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XRD spectral graph of PSS/PDDA with Br200 TiO2 on glass cover slip 
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XRD spectral graph of Binder alone on glass cover slip 
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XRD spectral graph of Binder with Br200 TiO2 on glass cover slip   
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XRD spectral graph of Binder with BrNMP TiO2 on glass cover slip 
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XRD spectral graph of Binder with vlp7000 TiO2 on glass cover slip   
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Poly(diallyldimethylammonium chloride) solution  (PDDA) 






Poly(4-styrenesulfonic acid) solution   (PSS) 
Line formula:  (C8H8O3S)n 
 
 
